0001164888 false --03-31 2022 Q3 0001164888 2021-04-01 2021-12-31 0001164888 2022-02-18 0001164888 2021-12-31 0001164888 2021-03-31 0001164888 us-gaap:SeriesAPreferredStockMember 2021-12-31 0001164888 us-gaap:SeriesAPreferredStockMember 2021-03-31 0001164888 us-gaap:SeriesBPreferredStockMember 2021-12-31 0001164888 us-gaap:SeriesBPreferredStockMember 2021-03-31 0001164888 2021-10-01 2021-12-31 0001164888 2020-10-01 2020-12-31 0001164888 2020-04-01 2020-12-31 0001164888 us-gaap:PreferredStockMember KBPH:PreferredAStockClassAOneATwoMember 2021-09-30 0001164888 us-gaap:PreferredStockMember KBPH:PreferredBStockBClassBOneBTwoBThreeMember 2021-09-30 0001164888 us-gaap:CommonStockMember 2021-09-30 0001164888 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001164888 us-gaap:RetainedEarningsMember 2021-09-30 0001164888 2021-09-30 0001164888 us-gaap:PreferredStockMember KBPH:PreferredAStockClassAOneATwoMember 2021-10-01 2021-12-31 0001164888 us-gaap:PreferredStockMember KBPH:PreferredBStockBClassBOneBTwoBThreeMember 2021-10-01 2021-12-31 0001164888 us-gaap:CommonStockMember 2021-10-01 2021-12-31 0001164888 us-gaap:AdditionalPaidInCapitalMember 2021-10-01 2021-12-31 0001164888 us-gaap:RetainedEarningsMember 2021-10-01 2021-12-31 0001164888 us-gaap:PreferredStockMember KBPH:PreferredAStockClassAOneATwoMember 2021-12-31 0001164888 us-gaap:PreferredStockMember KBPH:PreferredBStockBClassBOneBTwoBThreeMember 2021-12-31 0001164888 us-gaap:CommonStockMember 2021-12-31 0001164888 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001164888 us-gaap:RetainedEarningsMember 2021-12-31 0001164888 us-gaap:PreferredStockMember KBPH:PreferredAStockClassAOneATwoMember 2021-03-31 0001164888 us-gaap:PreferredStockMember KBPH:PreferredBStockBClassBOneBTwoBThreeMember 2021-03-31 0001164888 us-gaap:CommonStockMember 2021-03-31 0001164888 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001164888 us-gaap:RetainedEarningsMember 2021-03-31 0001164888 us-gaap:PreferredStockMember KBPH:PreferredAStockClassAOneATwoMember 2021-04-01 2021-12-31 0001164888 us-gaap:PreferredStockMember KBPH:PreferredBStockBClassBOneBTwoBThreeMember 2021-04-01 2021-12-31 0001164888 us-gaap:CommonStockMember 2021-04-01 2021-12-31 0001164888 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-12-31 0001164888 us-gaap:RetainedEarningsMember 2021-04-01 2021-12-31 0001164888 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2020-09-30 0001164888 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2020-09-30 0001164888 us-gaap:CommonStockMember 2020-09-30 0001164888 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001164888 us-gaap:RetainedEarningsMember 2020-09-30 0001164888 2020-09-30 0001164888 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2020-10-01 2020-12-31 0001164888 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2020-10-01 2020-12-31 0001164888 us-gaap:CommonStockMember 2020-10-01 2020-12-31 0001164888 us-gaap:AdditionalPaidInCapitalMember 2020-10-01 2020-12-31 0001164888 us-gaap:RetainedEarningsMember 2020-10-01 2020-12-31 0001164888 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2020-12-31 0001164888 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2020-12-31 0001164888 us-gaap:CommonStockMember 2020-12-31 0001164888 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001164888 us-gaap:RetainedEarningsMember 2020-12-31 0001164888 2020-12-31 0001164888 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2020-03-31 0001164888 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2020-03-31 0001164888 us-gaap:CommonStockMember 2020-03-31 0001164888 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001164888 us-gaap:RetainedEarningsMember 2020-03-31 0001164888 2020-03-31 0001164888 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2020-04-01 2020-12-31 0001164888 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2020-04-01 2020-12-31 0001164888 us-gaap:CommonStockMember 2020-04-01 2020-12-31 0001164888 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-12-31 0001164888 us-gaap:RetainedEarningsMember 2020-04-01 2020-12-31 0001164888 KBPH:PreferredBStockBClassBOneBTwoBThreeMember 2021-12-31 0001164888 KBPH:PreferredBStockClassBOneBThreeMember 2021-12-31 0001164888 us-gaap:SeriesBPreferredStockMember 2020-12-31 0001164888 KBPH:AbferoPharmaceuticalsIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSixPercentageDueDecemeberTwoThousandTwentyTwoMember 2021-12-31 0001164888 KBPH:AcheliosTherapeuticsIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageDueDecemeberTwoThousandTwentyOneMember 2021-12-31 0001164888 KBPH:AcheliosTherapeuticsIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageDueDecemeberTwoThousandTwentyOneOneMember 2021-12-31 0001164888 KBPH:AcheliosTherapeuticsIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageDueDecemeberTwoThousandTwentyOneTwoMember 2021-12-31 0001164888 KBPH:AcheliosTherapeuticsIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSidecarTwentyFivePercentageDiscountNoInterestMember 2021-12-31 0001164888 KBPH:AOADXIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteFourPercentageDueMayTwoThousandTwentyFourMember 2021-12-31 0001164888 KBPH:AvisiTechnologiesIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageDueJulyTwoThousandTwentyTwoMember 2021-12-31 0001164888 KBPH:BasepawsIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteOnePercentageDueAprilTwoThousandTwentyMember 2021-12-31 0001164888 KBPH:BasepawsIncOneMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSixPercentageDueOctoberTwoThousandThreeMember 2021-12-31 0001164888 KBPH:BeamSemiConductorIncMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageDueAprilTwoThousandTwentyTwoMember 2021-12-31 0001164888 KBPH:BeamSemiConductorIncMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageDueMarchTwoThousandTwentyOneMember 2021-12-31 0001164888 KBPH:BeamSemiConductorIncMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageDueMarchTwoThousandTwentyTwoMember 2021-12-31 0001164888 KBPH:ColabsIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSixPercentageDueFebruaryTwoThousandTwentyThreeMember 2021-12-31 0001164888 KBPH:CorinnovaIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSixPercentageDueDecemberTwoThousandTwentyFourMember 2021-12-31 0001164888 KBPH:CorinnovaIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSixPercentageDueDecemberTwoThousandTwentyFourOneMember 2021-12-31 0001164888 KBPH:CyberdonticsIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageDueSeptemberTwoThousandTwentyTwoMember 2021-12-31 0001164888 KBPH:CyberdonticsIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageDueFebruaryTwoThousandTwentyThreeMember 2021-12-31 0001164888 KBPH:CyberdonticsIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteZeroPercentageOnDueDateMember 2021-12-31 0001164888 KBPH:DeepBlueMedicalAdvancesIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSixPercentageDueJuneTwoThousandTwentyTwoMember 2021-12-31 0001164888 KBPH:DeepBlueMedicalAdvancesIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSixPercentageDueJuneTwoThousandTwentyTwoOneMember 2021-12-31 0001164888 KBPH:EveryKeyIncMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteFivePercentageDueDecemberTwoThousandTwentyThreeMember 2021-12-31 0001164888 KBPH:FemtoDXIncMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteTwelvePercentageDueDecemberTwoThousandTwentyTwoMember 2021-12-31 0001164888 KBPH:IdenticalIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteTwoPercentageDueMayTwoThousandTwentyTwoMember 2021-12-31 0001164888 KBPH:INBayTechnonlogyIncMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteTwelvePercentageDueOctoberTwoThousandTwentyMember 2021-12-31 0001164888 KBPH:INBayTechnonlogyIncMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteTwelvePercentageDueJulyTwoThousandTwentyOneMember 2021-12-31 0001164888 KBPH:INBayTechnonlogyIncMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteTwelvePercentageDueFebruaryTwoThousandTwentyTwoMember 2021-12-31 0001164888 KBPH:INBayTechnonlogyIncMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteTwelvePercentageDueDecemberTwoThousandTwentyTwoMember 2021-12-31 0001164888 KBPH:INBayTechnonlogyIncMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteTwelvePercentageDueDecemberTwoThousandTwentyThreeMember 2021-12-31 0001164888 KBPH:INBayTechnonlogyIncMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteTwelvePercentageDueDecemberTwoThousandTwentyThreeOneMember 2021-12-31 0001164888 KBPH:IrisRAndDGroupIncMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageDueMayTwoThousandTwentyThreeMember 2021-12-31 0001164888 KBPH:KianaAnalyticsMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteThreePercentageDueDecemberTwoThousandTwentyTwoMember 2021-12-31 0001164888 KBPH:KiotechMedicalIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSixPercentageDueDecemberTwoThousandTwentyMember 2021-12-31 0001164888 KBPH:KiotechMedicalIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSixPercentageDueNovemberTwoThousandTwentyTwoMember 2021-12-31 0001164888 KBPH:LifewaveBiomedicalIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSixPercentageDueDecemberTwoThousandTwentyMember 2021-12-31 0001164888 KBPH:LifewaveBiomedicalIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSixPercentageDueDecemberTwoThousandTwentyOnlyMember 2021-12-31 0001164888 KBPH:LifewaveBiomedicalIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSixPercentageDueDecemberTwoThousandTwentyOneMember 2021-12-31 0001164888 KBPH:LowellTherapeuticsIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageNoDueDateMember 2021-12-31 0001164888 KBPH:MMTronIncMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteFourPercentageDueAprilTwoThousandTwentyThreeMember 2021-12-31 0001164888 KBPH:NavauxIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSixPercentageDueDecemberTwoThousandTwentyThreeMember 2021-12-31 0001164888 KBPH:NeuroFoutyTwoIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageDueDecemberTwoThousandTwentyThreeMember 2021-12-31 0001164888 KBPH:NeuroFoutyTwoIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageDueNovemberTwoThousandTwentyThreeMember 2021-12-31 0001164888 KBPH:OctagonTherapeuticsIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteFivePercentageDueJuneTwoThousandTwentyOneMember 2021-12-31 0001164888 KBPH:OctagonTherapeuticsIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteFivePercentageDueJuneTwoThousandTwentyOneOnlyMember 2021-12-31 0001164888 KBPH:PerikineticsIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSixPercentageDueMayTwoThousandTwentyTwoMember 2021-12-31 0001164888 KBPH:PreviewMedicalIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSevenPercentageDueMayTwoThousandTwentyTwoMember 2021-12-31 0001164888 KBPH:PreviewMedicalIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSevenPercentageDueJanuaryTwoThousandTwentyThreeOnlyMember 2021-12-31 0001164888 KBPH:PromaxoIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteFivePercentageDueJulyTwoThousandTwentyTwoMember 2021-12-31 0001164888 KBPH:RheosIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageDueAugustTwoThousandTwentySixMember 2021-12-31 0001164888 KBPH:SaccharoIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSevenPercentageDueSeptemberTwoThousandTwentyTwoMember 2021-12-31 0001164888 KBPH:SageMedicCorpMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageDueAprilTwoThousandTwentyOnePlusWarrantsMember 2021-12-31 0001164888 KBPH:SageMedicCorpMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageDueDecemberTwoThousandTwentyTwoPlusWarrantsMember 2021-12-31 0001164888 KBPH:SealRockTherapeuticsIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSixPercentageDueJuneTwoThousandTwentyThreeMember 2021-12-31 0001164888 KBPH:SensingElectromagneticPlusCorpMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteFullyReservedMember 2021-12-31 0001164888 KBPH:SensingElectromagneticPlusCorpMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteFullyReservedOneMember 2021-12-31 0001164888 KBPH:ShyftMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSixPercentageAprilTwoThousandTwentyThreeMember 2021-12-31 0001164888 KBPH:SinglePassIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSixPercentageAprilTwoThousandTwentyFourMember 2021-12-31 0001164888 KBPH:ValfixMedicalIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageDecemberTwoThousandTwentyOneMember 2021-12-31 0001164888 KBPH:XpanIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageMarchTwoThousandTwentyTwoMember 2021-12-31 0001164888 KBPH:XpanIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageJuneTwoThousandTwentyTwoMember 2021-12-31 0001164888 KBPH:XpanIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageJuneTwoThousandTwentyTwoOnlyMember 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember country:US 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember country:CA 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:RestOfWorldMember 2021-12-31 0001164888 KBPH:AltisBiosystemsMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredMember 2021-12-31 0001164888 KBPH:AstrocytePharmaceuticalsIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesAPreferredStockMember 2021-12-31 0001164888 KBPH:CnoteGroupIncMember KBPH:FintechMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedTwoPreferredMember 2021-12-31 0001164888 KBPH:CnoteGroupIncMember KBPH:FintechMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedThreePreferredMember 2021-12-31 0001164888 KBPH:ColabsIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAOnePreferredMember 2021-12-31 0001164888 KBPH:ConnectusServicesLtdMember KBPH:TechnologyMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredMember 2021-12-31 0001164888 KBPH:DeepBlueMedicalAdvancesIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesAPreferredStockMember 2021-12-31 0001164888 KBPH:DistasenseIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesCPreferredStockMember 2021-12-31 0001164888 KBPH:EumentisThereapeuticsIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesAPreferredStockMember 2021-12-31 0001164888 KBPH:FemtoDXIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesAPreferredStockMember 2021-12-31 0001164888 KBPH:HealionicsCorporationMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAOnePreferredMember 2021-12-31 0001164888 KBPH:ILumenScientificIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAPreferredPlusWarrantsMember 2021-12-31 0001164888 KBPH:ILumenScientificIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAPreferredPlusWarrantsOneMember 2021-12-31 0001164888 KBPH:InhalonBiopharmaIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredMember 2021-12-31 0001164888 KBPH:KitotechMedicalIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesBPreferredMember 2021-12-31 0001164888 KBPH:LightLineMedicalIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredConvertedNoteMember 2021-12-31 0001164888 KBPH:LightLineMedicalIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredConvertedNoteOneMember 2021-12-31 0001164888 KBPH:LightLineMedicalIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredMember 2021-12-31 0001164888 KBPH:LightLineMedicalIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAPreferredPlusWarrantsMember 2021-12-31 0001164888 KBPH:LowellTherapeuticsIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesAPreferredStockMember 2021-12-31 0001164888 KBPH:LowellTherapeuticsIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAPreferredStockOneMember 2021-12-31 0001164888 KBPH:LowellTherapeuticsIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesBPreferredStockMember 2021-12-31 0001164888 KBPH:MakaniScienceIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredMember 2021-12-31 0001164888 KBPH:MicronicTechnologiesIncMember KBPH:TechnologyMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedOnePreferredPlusWarrantsMember 2021-12-31 0001164888 KBPH:NanochonIncMember KBPH:TechnologyMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredPlusWarrantsMember 2021-12-31 0001164888 KBPH:NeuroflowIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedTwoPreferredMember 2021-12-31 0001164888 KBPH:NeuroflowIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesBPreferredStockMember 2021-12-31 0001164888 KBPH:NewViewSurgicalIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAOnePreferredMember 2021-12-31 0001164888 KBPH:NewViewSurgicalIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAOnePreferredOneMember 2021-12-31 0001164888 KBPH:OrionBiotechnologyIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesAPreferredStockMember 2021-12-31 0001164888 KBPH:OtomagneticsIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAOnePreferredPlusWarrantsMember 2021-12-31 0001164888 KBPH:PartheousIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesAPreferredStockMember 2021-12-31 0001164888 KBPH:PromaxoIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesBOnePreferredConvertedNoteMember 2021-12-31 0001164888 KBPH:SageMedicCorpMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAPreferredMember 2021-12-31 0001164888 KBPH:SealRockTherapeuticsIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredConvertedNoteMember 2021-12-31 0001164888 KBPH:ShyftFKACraterGroupIncMember KBPH:TechnologyMember KBPH:PreferredInvestmentsMember KBPH:SeriesAOnePreferredMember 2021-12-31 0001164888 KBPH:ShyftFKACraterGroupIncMember KBPH:TechnologyMember KBPH:PreferredInvestmentsMember KBPH:SeriesAPreferredConvertedNoteMember 2021-12-31 0001164888 KBPH:ShyftFKACraterGroupIncMember KBPH:TechnologyMember KBPH:PreferredInvestmentsMember KBPH:SeriesAOnePreferredConvertedNoteMember 2021-12-31 0001164888 KBPH:TrellisBioscienceLLCMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesBPreferredPlusWarrantsMember 2021-12-31 0001164888 KBPH:TrellisBioscienceLLCMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesBPreferredPlusWarrantsOneMember 2021-12-31 0001164888 KBPH:TrellisBioscienceLLCMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesBPreferredPlusWarrantsTwoMember 2021-12-31 0001164888 KBPH:TrioLabsIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredMember 2021-12-31 0001164888 KBPH:ValfixMedicalIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredMember 2021-12-31 0001164888 KBPH:VesteckIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesAPreferredStockMember 2021-12-31 0001164888 KBPH:VisgenxIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedOnePreferredConvertedNoteMember 2021-12-31 0001164888 KBPH:VisgenxIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredConvertedNoteMember 2021-12-31 0001164888 KBPH:VisgenxIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredConvertedNoteOneMember 2021-12-31 0001164888 KBPH:PreferredInvestmentsMember 2021-12-31 0001164888 KBPH:PreferredInvestmentsMember country:US 2021-12-31 0001164888 KBPH:PreferredInvestmentsMember country:CA 2021-12-31 0001164888 KBPH:PreferredInvestmentsMember KBPH:RestOfWorldMember 2021-12-31 0001164888 KBPH:BendaRXCorpMember KBPH:LifeScienceMember KBPH:CommonStockInvestmentsMember us-gaap:CommonStockMember 2021-12-31 0001164888 KBPH:BendaRXCorpMember KBPH:LifeScienceMember KBPH:CommonStockInvestmentsMember KBPH:CommonStockOneMember 2021-12-31 0001164888 KBPH:KuantsolIncMember KBPH:TechnologyMember KBPH:CommonStockInvestmentsMember us-gaap:CommonStockMember 2021-12-31 0001164888 KBPH:CommonStockInvestmentMember 2021-12-31 0001164888 KBPH:CommonStockInvestmentsMember country:US 2021-12-31 0001164888 KBPH:CommonStockInvestmentsMember country:CA 2021-12-31 0001164888 KBPH:CommonStockInvestmentsMember KBPH:RestOfWorldMember 2021-12-31 0001164888 KBPH:CommonStockInvestmentsMember 2021-12-31 0001164888 KBPH:BoardwalkTechMember KBPH:TechnologyMember KBPH:PublicCommonStockInvestmentsMember us-gaap:CommonStockMember 2021-12-31 0001164888 KBPH:BoardwalkTechMember KBPH:TechnologyMember KBPH:PublicCommonStockInvestmentsMember KBPH:CommonStockOneMember 2021-12-31 0001164888 KBPH:SanabyHealthAcquisitionCorpOneMember KBPH:LifeScienceMember KBPH:PublicCommonStockInvestmentsMember us-gaap:CommonStockMember 2021-12-31 0001164888 KBPH:PublicCommonStockInvestmentMember 2021-12-31 0001164888 KBPH:PublicCommonStockInvestmentsMember country:US 2021-12-31 0001164888 KBPH:PublicCommonStockInvestmentsMember country:CA 2021-12-31 0001164888 KBPH:PublicCommonStockInvestmentsMember KBPH:RestOfWorldMember 2021-12-31 0001164888 KBPH:PublicCommonStockInvestmentsMember 2021-12-31 0001164888 KBPH:AOADXIncMember KBPH:LifeScienceMember KBPH:SafeInvestmentsMember KBPH:SafeMember 2021-12-31 0001164888 KBPH:InfinidomeLtdMember KBPH:TechnologyMember KBPH:SafeInvestmentsMember KBPH:SafeMember 2021-12-31 0001164888 KBPH:InfinidomeLtdMember KBPH:TechnologyMember KBPH:SafeInvestmentsMember KBPH:SafeOneMember 2021-12-31 0001164888 KBPH:InfinidomeLtdMember KBPH:TechnologyMember KBPH:SafeInvestmentsMember KBPH:SafeTwoMember 2021-12-31 0001164888 KBPH:MadorraIncMember KBPH:LifeScienceMember KBPH:SafeInvestmentsMember KBPH:SafeMember 2021-12-31 0001164888 KBPH:MitreMedicalCorpMember KBPH:LifeScienceMember KBPH:SafeInvestmentsMember KBPH:SafeMember 2021-12-31 0001164888 KBPH:MitreMedicalCorpMember KBPH:LifeScienceMember KBPH:SafeInvestmentsMember KBPH:SafeOneMember 2021-12-31 0001164888 KBPH:OrionBiotechnologyIncMember KBPH:LifeScienceMember KBPH:SafeInvestmentsMember KBPH:SafeMember 2021-12-31 0001164888 KBPH:PolymertalIncMember KBPH:TechnologyMember KBPH:SafeInvestmentsMember KBPH:SafeMember 2021-12-31 0001164888 KBPH:SafeInvestmentsMember 2021-12-31 0001164888 KBPH:SafeInvestmentsMember country:US 2021-12-31 0001164888 KBPH:SafeInvestmentsMember country:CA 2021-12-31 0001164888 KBPH:SafeInvestmentsMember KBPH:RestOfWorldMember 2021-12-31 0001164888 KBPH:EnduralockLLCMember KBPH:TechnologyMember KBPH:OtherInvestmentMember KBPH:SeriesAOneOwnershipUnitsMember 2021-12-31 0001164888 KBPH:EnduralockLLCMember KBPH:TechnologyMember KBPH:OtherInvestmentMember KBPH:SeriesAOneOwnershipUnitsOneMember 2021-12-31 0001164888 KBPH:ExodosLifeSciencesLPMember KBPH:LifeScienceMember KBPH:OtherInvestmentMember KBPH:SeriesAOneOwnershipUnitsMember 2021-12-31 0001164888 KBPH:GreenSunMedicalLLCMember KBPH:LifeScienceMember KBPH:OtherInvestmentMember KBPH:ClassAOnePreferredOwnershipUnitsMember 2021-12-31 0001164888 KBPH:GreenSunMedicalLLCMember KBPH:LifeScienceMember KBPH:OtherInvestmentMember KBPH:ClassAOnePreferredOwnershipUnitsOneMember 2021-12-31 0001164888 KBPH:GreenSunMedicalLLCMember KBPH:LifeScienceMember KBPH:OtherInvestmentMember KBPH:ClassAOnePreferredOwnershipUnitsTwoMember 2021-12-31 0001164888 KBPH:GreenSunMedicalLLCMember KBPH:LifeScienceMember KBPH:OtherInvestmentMember KBPH:ClassAOnePreferredOwnershipUnitsThreeMember 2021-12-31 0001164888 KBPH:RisoCapitalFundILPMember KBPH:TechnologyMember KBPH:OtherInvestmentMember KBPH:OwnershipUnitsMember 2021-12-31 0001164888 KBPH:RisoCapitalFundILPMember KBPH:TechnologyMember KBPH:OtherInvestmentMember KBPH:OwnershipUnitsOneMember 2021-12-31 0001164888 KBPH:OtherInvestmentMember 2021-12-31 0001164888 KBPH:OtherInvestmentMember country:US 2021-12-31 0001164888 KBPH:OtherInvestmentMember country:CA 2021-12-31 0001164888 KBPH:OtherInvestmentMember KBPH:RestOfWorldMember 2021-12-31 0001164888 country:US 2021-12-31 0001164888 country:CA 2021-12-31 0001164888 KBPH:RestOfWorldMember 2021-12-31 0001164888 KBPH:ConvertibleNoteEightPercentageDueDecemeberTwoThousandTwentyOneMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:AcheliosTherapeuticsIncMember 2021-03-31 0001164888 KBPH:ConvertibleNoteEightPercentageDueDecemeberTwoThousandTwentyOneOneMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:AcheliosTherapeuticsIncMember 2021-03-31 0001164888 KBPH:ConvertibleNoteEightPercentageDueDecemeberTwoThousandTwentyOneTwoMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:AcheliosTherapeuticsIncMember 2021-03-31 0001164888 KBPH:ConvertibleNoteEightPercentageDueJulyTwoThousandTwentyTwoMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:AvisiTechnologiesIncMember 2021-03-31 0001164888 KBPH:ConvertibleNoteOnePercentageDueAprilTwoThousandTwentyMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:BasepawsIncMember 2021-03-31 0001164888 KBPH:ConvertibleNoteEightPercentageDueAprilTwoThousandTwentyTwoMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:BeamSemiConductorIncMember 2021-03-31 0001164888 KBPH:ConvertibleNoteEightPercentageDueMarchTwoThousandTwentyOneMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:BeamSemiConductorIncMember 2021-03-31 0001164888 KBPH:ConvertibleNoteSixPercentageDueDecemberTwoThousandTwentyFourMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:CorinnovaIncMember 2021-03-31 0001164888 KBPH:ConvertibleNoteEightPercentageDueSeptemberTwoThousandTwentyTwoMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:CyberdonticsIncMember 2021-03-31 0001164888 KBPH:ConvertibleNoteEightPercentageDueFebruaryTwoThousandTwentyThreeMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:CyberdonticsIncMember 2021-03-31 0001164888 KBPH:ConvertibleNoteZeroPercentageOnDueDateMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:CyberdonticsIncMember 2021-03-31 0001164888 KBPH:ConvertibleNoteSixPercentageDueJuneTwoThousandTwentyTwoMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:DeepBlueMedicalAdvancesIncMember 2021-03-31 0001164888 KBPH:ConvertibleNoteFivePercentageDueDecemberTwoThousandTwentyThreeMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:EveryKeyIncMember 2021-03-31 0001164888 KBPH:ConvertibleNoteTwoPercentageDueMayTwoThousandTwentyTwoMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:IdenticalIncMember 2021-03-31 0001164888 KBPH:ConvertibleNoteTwelvePercentageDueOctoberTwoThousandTwentyMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:INBayTechnonlogyIncMember 2021-03-31 0001164888 KBPH:ConvertibleNoteTwelvePercentageDueJulyTwoThousandTwentyOneMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:INBayTechnonlogyIncMember 2021-03-31 0001164888 KBPH:ConvertibleNoteTwelvePercentageDueFebruaryTwoThousandTwentyTwoMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:INBayTechnonlogyIncMember 2021-03-31 0001164888 KBPH:ConvertibleNoteTwelvePercentageDueDecemberTwoThousandTwentyTwoMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:INBayTechnonlogyIncMember 2021-03-31 0001164888 KBPH:ConvertibleNoteThreePercentageDueDecemberTwoThousandTwentyTwoMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:KianaAnalyticsMember 2021-03-31 0001164888 KBPH:ConvertibleNoteSixPercentageDueDecemberTwoThousandTwentyMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:KiotechMedicalIncMember 2021-03-31 0001164888 KBPH:ConvertibleNoteSixPercentageDueNovemberTwoThousandTwentyTwoMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:KiotechMedicalIncMember 2021-03-31 0001164888 KBPH:ConvertibleNoteSixPercentageDueDecemberTwoThousandTwentyMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:LifewaveBiomedicalIncMember 2021-03-31 0001164888 KBPH:ConvertibleNoteSixPercentageDueDecemberTwoThousandTwentyOnlyMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:LifewaveBiomedicalIncMember 2021-03-31 0001164888 KBPH:ConvertibleNoteSixPercentageDueDecemberTwoThousandTwentyThreeMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:NavauxIncMember 2021-03-31 0001164888 KBPH:ConvertibleNoteEightPercentageDueDecemberTwoThousandTwentyThreeMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:NeuroFoutyTwoIncMember 2021-03-31 0001164888 KBPH:ConvertibleNoteFivePercentageDueJuneTwoThousandTwentyOneMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:OctagonTherapeuticsIncMember 2021-03-31 0001164888 KBPH:ConvertibleNoteFivePercentageDueJuneTwoThousandTwentyOneOnlyMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:OctagonTherapeuticsIncMember 2021-03-31 0001164888 KBPH:ConvertibleNoteSixPercentageDueMayTwoThousandTwentyTwoMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:PerikineticsIncMember 2021-03-31 0001164888 KBPH:PreviewMedicalIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSevenPercentageDueJanuaryTwoThousandTwentyThreeMember 2021-03-31 0001164888 KBPH:ConvertibleNoteEightPercentageDueAprilTwoThousandTwentyOnePlusWarrantsMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:SageMedicCorpMember 2021-03-31 0001164888 KBPH:ConvertibleNoteEightPercentageDueDecemberTwoThousandTwentyTwoPlusWarrantsMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:SageMedicCorpMember 2021-03-31 0001164888 KBPH:ConvertibleNoteFullyReservedMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:SensingElectromagneticPlusCorpMember 2021-03-31 0001164888 KBPH:ConvertibleNoteFullyReservedOneMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:SensingElectromagneticPlusCorpMember 2021-03-31 0001164888 KBPH:ConvertibleNoteEightPercentageDecemberTwoThousandTwentyOneMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ValfixMedicalIncMember 2021-03-31 0001164888 KBPH:ConvertibleNoteEightPercentageMarchTwoThousandTwentyTwoMember KBPH:LifeScienceMember us-gaap:CorporateNoteSecuritiesMember KBPH:XpanIncMember 2021-03-31 0001164888 KBPH:ConvertibleNoteEightPercentageJuneTwoThousandTwentyTwoMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:XpanIncMember 2021-03-31 0001164888 KBPH:ConvertibleNoteEightPercentageJuneTwoThousandTwentyTwoOnlyMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:XpanIncMember 2021-03-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember 2021-03-31 0001164888 country:US us-gaap:ConvertibleDebtSecuritiesMember 2021-03-31 0001164888 country:CA us-gaap:ConvertibleDebtSecuritiesMember 2021-03-31 0001164888 KBPH:RestOfWorldMember us-gaap:ConvertibleDebtSecuritiesMember 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredMember KBPH:AltisBiosystemsMember 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesAPreferredStockMember KBPH:AstrocytePharmaceuticalsIncMember 2021-03-31 0001164888 KBPH:FintechMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedTwoPreferredMember KBPH:CnoteGroupIncMember 2021-03-31 0001164888 KBPH:FintechMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedThreePreferredMember KBPH:CnoteGroupIncMember 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAOnePreferredMember KBPH:ColabsIncMember 2021-03-31 0001164888 KBPH:TechnologyMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredMember KBPH:ConnectusServicesLtdMember 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesAPreferredStockMember KBPH:DeepBlueMedicalAdvancesIncMember 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesAPreferredStockMember KBPH:EumentisThereapeuticsIncMember 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesAPreferredStockMember KBPH:FemtoDXIncMember 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAPreferredPlusWarrantsMember KBPH:ILumenScientificIncMember 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAPreferredPlusWarrantsOneMember KBPH:ILumenScientificIncMember 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredMember KBPH:InhalonBiopharmaIncMember 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredConvertedNoteMember KBPH:LightLineMedicalIncMember 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredConvertedNoteOneMember KBPH:LightLineMedicalIncMember 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredMember KBPH:LightLineMedicalIncMember 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAPreferredPlusWarrantsMember KBPH:LightLineMedicalIncMember 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesAPreferredStockMember KBPH:LowellTherapeuticsIncMember 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAPreferredStockOneMember KBPH:LowellTherapeuticsIncMember 2021-03-31 0001164888 KBPH:TechnologyMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedOnePreferredPlusWarrantsMember KBPH:MicronicTechnologiesIncMember 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedTwoPreferredMember KBPH:NeuroflowIncMember 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesBPreferredStockMember KBPH:NeuroflowIncMember 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAOnePreferredMember KBPH:NewViewSurgicalIncMember 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAOnePreferredPlusWarrantsMember KBPH:OtomagneticsIncMember 2021-03-31 0001164888 KBPH:PromaxoIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesBOnePreferredConvertedNoteMember 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredConvertedNoteMember KBPH:SealRockTherapeuticsIncMember 2021-03-31 0001164888 KBPH:TechnologyMember KBPH:PreferredInvestmentsMember KBPH:SeriesAOnePreferredMember KBPH:ShyftFKACraterGroupIncMember 2021-03-31 0001164888 KBPH:TechnologyMember KBPH:PreferredInvestmentsMember KBPH:SeriesAPreferredConvertedNoteMember KBPH:ShyftFKACraterGroupIncMember 2021-03-31 0001164888 KBPH:TechnologyMember KBPH:PreferredInvestmentsMember KBPH:SeriesAOnePreferredConvertedNoteMember KBPH:ShyftFKACraterGroupIncMember 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesBPreferredPlusWarrantsMember KBPH:TrellisBioscienceLLCMember 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesBPreferredPlusWarrantsOneMember KBPH:TrellisBioscienceLLCMember 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesBPreferredPlusWarrantsTwoMember KBPH:TrellisBioscienceLLCMember 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredMember KBPH:ValfixMedicalIncMember 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedOnePreferredConvertedNoteMember KBPH:VisgenxIncMember 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredConvertedNoteMember KBPH:VisgenxIncMember 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredConvertedNoteOneMember KBPH:VisgenxIncMember 2021-03-31 0001164888 KBPH:PreferredInvestmentsMember 2021-03-31 0001164888 country:US KBPH:PreferredInvestmentsMember 2021-03-31 0001164888 country:CA KBPH:PreferredInvestmentsMember 2021-03-31 0001164888 KBPH:RestOfWorldMember KBPH:PreferredInvestmentsMember 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:CommonStockInvestmentsMember us-gaap:CommonStockMember KBPH:BendaRXCorpMember 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:CommonStockInvestmentsMember KBPH:CommonStockOneMember KBPH:BendaRXCorpMember 2021-03-31 0001164888 KBPH:TechnologyMember KBPH:CommonStockInvestmentsMember us-gaap:CommonStockMember KBPH:BoardwalkTechMember 2021-03-31 0001164888 KBPH:CommonStockInvestmentsMember 2021-03-31 0001164888 country:US KBPH:CommonStockInvestmentsMember 2021-03-31 0001164888 country:CA KBPH:CommonStockInvestmentsMember 2021-03-31 0001164888 KBPH:RestOfWorldMember KBPH:CommonStockInvestmentsMember 2021-03-31 0001164888 KBPH:InfinidomeLtdMember KBPH:TechnologyMember KBPH:SafeInvestmentsMember KBPH:SafeMember 2021-03-31 0001164888 KBPH:InfinidomeLtdMember KBPH:TechnologyMember KBPH:SafeInvestmentsMember KBPH:SafeOneMember 2021-03-31 0001164888 KBPH:MitreMedicalCorpMember KBPH:LifeScienceMember KBPH:SafeInvestmentsMember KBPH:SafeMember 2021-03-31 0001164888 KBPH:MitreMedicalCorpMember KBPH:LifeScienceMember KBPH:SafeInvestmentsMember KBPH:SafeOneMember 2021-03-31 0001164888 KBPH:OrionBiotechnologyIncMember KBPH:LifeScienceMember KBPH:SafeInvestmentsMember KBPH:SafeMember 2021-03-31 0001164888 KBPH:SafeInvestmentsMember 2021-03-31 0001164888 country:US KBPH:SafeInvestmentsMember 2021-03-31 0001164888 country:CA KBPH:SafeInvestmentsMember 2021-03-31 0001164888 KBPH:RestOfWorldMember KBPH:SafeInvestmentsMember 2021-03-31 0001164888 KBPH:EnduralockLLCMember KBPH:TechnologyMember KBPH:OtherInvestmentMember KBPH:SeriesAOneOwnershipUnitsMember 2021-03-31 0001164888 KBPH:SeriesAOneOwnershipUnitsOneMember KBPH:TechnologyMember KBPH:OtherInvestmentMember KBPH:EnduralockLLCMember 2021-03-31 0001164888 KBPH:ExodosLifeSciencesLPMember KBPH:LifeScienceMember KBPH:OtherInvestmentMember KBPH:SeriesAOneOwnershipUnitsMember 2021-03-31 0001164888 KBPH:ClassAOnePreferredOwnershipUnitsMember KBPH:LifeScienceMember KBPH:OtherInvestmentMember KBPH:GreenSunMedicalLLCMember 2021-03-31 0001164888 KBPH:ClassAOnePreferredOwnershipUnitsOneMember KBPH:LifeScienceMember KBPH:OtherInvestmentMember KBPH:GreenSunMedicalLLCMember 2021-03-31 0001164888 KBPH:ClassAOnePreferredOwnershipUnitsTwoMember KBPH:LifeScienceMember KBPH:OtherInvestmentMember KBPH:GreenSunMedicalLLCMember 2021-03-31 0001164888 KBPH:OwnershipUnitsMember KBPH:TechnologyMember KBPH:OtherInvestmentMember KBPH:RisoCapitalFundILPMember 2021-03-31 0001164888 KBPH:OtherInvestmentMember 2021-03-31 0001164888 country:US KBPH:OtherInvestmentMember 2021-03-31 0001164888 country:CA KBPH:OtherInvestmentMember 2021-03-31 0001164888 KBPH:RestOfWorldMember KBPH:OtherInvestmentMember 2021-03-31 0001164888 country:US 2021-03-31 0001164888 country:CA 2021-03-31 0001164888 KBPH:RestOfWorldMember 2021-03-31 0001164888 KBPH:AbferoPharmaceuticalsIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSixPercentageDueDecemeberTwoThousandTwentyTwoMember 2021-04-01 2021-12-31 0001164888 KBPH:AcheliosTherapeuticsIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageDueDecemeberTwoThousandTwentyOneMember 2021-04-01 2021-12-31 0001164888 KBPH:AcheliosTherapeuticsIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageDueDecemeberTwoThousandTwentyOneOneMember 2021-04-01 2021-12-31 0001164888 KBPH:AcheliosTherapeuticsIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageDueDecemeberTwoThousandTwentyOneTwoMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:AOADXIncMember KBPH:LifeScienceMember KBPH:ConvertibleNoteFourPercentageDueMayTwoThousandTwentyFourMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:AvisiTechnologiesIncMember KBPH:LifeScienceMember KBPH:ConvertibleNoteEightPercentageDueJulyTwoThousandTwentyTwoMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:BasepawsIncMember KBPH:LifeScienceMember KBPH:ConvertibleNoteOnePercentageDueAprilTwoThousandTwentyMember 2021-04-01 2021-12-31 0001164888 KBPH:BasepawsIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSixPercentageDueOctoberTwoThousandThreeMember 2021-12-31 0001164888 KBPH:BasepawsIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSixPercentageDueOctoberTwoThousandThreeMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:BeamSemiConductorIncMember KBPH:TechnologyMember KBPH:ConvertibleNoteEightPercentageDueAprilTwoThousandTwentyTwoMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:BeamSemiConductorIncMember KBPH:TechnologyMember KBPH:ConvertibleNoteEightPercentageDueMarchTwoThousandTwentyOneMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:BeamSemiConductorIncMember KBPH:TechnologyMember KBPH:ConvertibleNoteEightPercentageDueMarchTwoThousandTwentyTwoMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:ColabsIncMember KBPH:LifeScienceMember KBPH:ConvertibleNoteSixPercentageDueFebruaryTwoThousandTwentyThreeMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:CorinnovaIncMember KBPH:LifeScienceMember KBPH:ConvertibleNoteSixPercentageDueDecemberTwoThousandTwentyFourMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:CorinnovaIncMember KBPH:LifeScienceMember KBPH:ConvertibleNoteSixPercentageDueDecemberTwoThousandTwentyFourOneMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:CyberdonticsIncMember KBPH:LifeScienceMember KBPH:ConvertibleNoteEightPercentageDueSeptemberTwoThousandTwentyTwoMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:CyberdonticsIncMember KBPH:LifeScienceMember KBPH:ConvertibleNoteEightPercentageDueFebruaryTwoThousandTwentyThreeMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:DeepBlueMedicalAdvancesIncMember KBPH:LifeScienceMember KBPH:ConvertibleNoteSixPercentageDueJuneTwoThousandTwentyTwoMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:DeepBlueMedicalAdvancesIncMember KBPH:LifeScienceMember KBPH:ConvertibleNoteSixPercentageDueJuneTwoThousandTwentyTwoOneMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:EveryKeyIncMember KBPH:TechnologyMember KBPH:ConvertibleNoteFivePercentageDueDecemberTwoThousandTwentyThreeMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:FemtoDXIncMember KBPH:TechnologyMember KBPH:ConvertibleNoteTwelvePercentageDueDecemberTwoThousandTwentyTwoMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:IdenticalIncMember KBPH:LifeScienceMember KBPH:ConvertibleNoteTwoPercentageDueMayTwoThousandTwentyTwoMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:INBayTechnonlogyIncMember KBPH:TechnologyMember KBPH:ConvertibleNoteTwelvePercentageDueOctoberTwoThousandTwentyMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:INBayTechnonlogyIncMember KBPH:TechnologyMember KBPH:ConvertibleNoteTwelvePercentageDueJulyTwoThousandTwentyOneMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:INBayTechnonlogyIncMember KBPH:TechnologyMember KBPH:ConvertibleNoteTwelvePercentageDueFebruaryTwoThousandTwentyTwoMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:INBayTechnonlogyIncMember KBPH:TechnologyMember KBPH:ConvertibleNoteTwelvePercentageDueDecemberTwoThousandTwentyTwoMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:INBayTechnonlogyIncMember KBPH:TechnologyMember KBPH:ConvertibleNoteTwelvePercentageDueDecemberTwoThousandTwentyThreeMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:INBayTechnonlogyIncMember KBPH:TechnologyMember KBPH:ConvertibleNoteTwelvePercentageDueDecemberTwoThousandTwentyThreeOneMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:IrisRAndDGroupIncMember KBPH:TechnologyMember KBPH:ConvertibleNoteEightPercentageDueMayTwoThousandTwentyThreeMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:KianaAnalyticsMember KBPH:TechnologyMember KBPH:ConvertibleNoteThreePercentageDueDecemberTwoThousandTwentyTwoMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:KiotechMedicalIncMember KBPH:LifeScienceMember KBPH:ConvertibleNoteSixPercentageDueDecemberTwoThousandTwentyMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:KiotechMedicalIncMember KBPH:LifeScienceMember KBPH:ConvertibleNoteSixPercentageDueNovemberTwoThousandTwentyTwoMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:LifewaveBiomedicalIncMember KBPH:LifeScienceMember KBPH:ConvertibleNoteSixPercentageDueDecemberTwoThousandTwentyMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:LifewaveBiomedicalIncMember KBPH:LifeScienceMember KBPH:ConvertibleNoteSixPercentageDueDecemberTwoThousandTwentyOnlyMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:LifewaveBiomedicalIncMember KBPH:LifeScienceMember KBPH:ConvertibleNoteSixPercentageDueDecemberTwoThousandTwentyOneMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:MMTronIncMember KBPH:TechnologyMember KBPH:ConvertibleNoteFourPercentageDueAprilTwoThousandTwentyThreeMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:NavauxIncMember KBPH:LifeScienceMember KBPH:ConvertibleNoteSixPercentageDueDecemberTwoThousandTwentyThreeMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:NeuroFoutyTwoIncMember KBPH:LifeScienceMember KBPH:ConvertibleNoteEightPercentageDueDecemberTwoThousandTwentyThreeMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:NeuroFoutyTwoIncMember KBPH:LifeScienceMember KBPH:ConvertibleNoteEightPercentageDueNovemberTwoThousandTwentyThreeMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:OctagonTherapeuticsIncMember KBPH:LifeScienceMember KBPH:ConvertibleNoteFivePercentageDueJuneTwoThousandTwentyOneMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:OctagonTherapeuticsIncMember KBPH:LifeScienceMember KBPH:ConvertibleNoteFivePercentageDueJuneTwoThousandTwentyOneOnlyMember 2021-04-01 2021-12-31 0001164888 KBPH:PerikineticsIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSixPercentageDueMayTwoThousandTwentyTwoMember 2021-04-01 2021-12-31 0001164888 KBPH:PreviewMedicalIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSevenPercentageDueMayTwoThousandTwentyTwoMember 2021-04-01 2021-12-31 0001164888 KBPH:PreviewMedicalIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSevenPercentageDueJanuaryTwoThousandTwentyThreeMember 2021-12-31 0001164888 KBPH:PreviewMedicalIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSevenPercentageDueJanuaryTwoThousandTwentyThreeMember 2021-04-01 2021-12-31 0001164888 KBPH:PromaxoIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteFivePercentageDueJulyTwoThousandTwentyTwoMember 2021-04-01 2021-12-31 0001164888 KBPH:RheosIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageDueAugustTwoThousandTwentySixMember 2021-04-01 2021-12-31 0001164888 KBPH:SaccharoIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSevenPercentageDueSeptemberTwoThousandTwentyTwoMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:SageMedicCorpMember KBPH:LifeScienceMember KBPH:ConvertibleNoteEightPercentageDueAprilTwoThousandTwentyOnePlusWarrantsMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:SageMedicCorpMember KBPH:LifeScienceMember KBPH:ConvertibleNoteEightPercentageDueDecemberTwoThousandTwentyTwoPlusWarrantsMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:SealRockTherapeuticsIncMember KBPH:LifeScienceMember KBPH:ConvertibleNoteSixPercentageDueJuneTwoThousandTwentyThreeMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:ShyftMember KBPH:LifeScienceMember KBPH:ConvertibleNoteSixPercentageAprilTwoThousandTwentyThreeMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:SinglePassIncMember KBPH:LifeScienceMember KBPH:ConvertibleNoteSixPercentageAprilTwoThousandTwentyFourMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:ValfixMedicalIncMember KBPH:LifeScienceMember KBPH:ConvertibleNoteEightPercentageDecemberTwoThousandTwentyOneMember 2021-04-01 2021-12-31 0001164888 KBPH:XpanIncMember KBPH:LifeScienceMember us-gaap:CorporateNoteSecuritiesMember KBPH:ConvertibleNoteEightPercentageMarchTwoThousandTwentyTwoMember 2021-12-31 0001164888 us-gaap:CorporateNoteSecuritiesMember KBPH:XpanIncMember KBPH:LifeScienceMember KBPH:ConvertibleNoteEightPercentageMarchTwoThousandTwentyTwoMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:XpanIncMember KBPH:LifeScienceMember KBPH:ConvertibleNoteEightPercentageJuneTwoThousandTwentyTwoMember 2021-04-01 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember KBPH:XpanIncMember KBPH:LifeScienceMember KBPH:ConvertibleNoteEightPercentageJuneTwoThousandTwentyTwoOnlyMember 2021-04-01 2021-12-31 0001164888 KBPH:AltisBiosystemsMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredMember 2021-04-01 2021-12-31 0001164888 KBPH:AstrocytePharmaceuticalsIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesAPreferredStockMember 2021-04-01 2021-12-31 0001164888 KBPH:CnoteGroupIncMember KBPH:FintechMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedTwoPreferredMember 2021-04-01 2021-12-31 0001164888 KBPH:CnoteGroupIncMember KBPH:FintechMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedThreePreferredMember 2021-04-01 2021-12-31 0001164888 KBPH:ColabsIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAOnePreferredMember 2021-04-01 2021-12-31 0001164888 KBPH:ConnectusServicesLtdMember KBPH:TechnologyMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredMember 2021-04-01 2021-12-31 0001164888 KBPH:DeepBlueMedicalAdvancesIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesAPreferredStockMember 2021-04-01 2021-12-31 0001164888 KBPH:DistasenseIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesAPreferredStockMember 2021-04-01 2021-12-31 0001164888 KBPH:EumentisThereapeuticsIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesAPreferredStockMember 2021-04-01 2021-12-31 0001164888 KBPH:FemtoDXIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesAPreferredStockMember 2021-04-01 2021-12-31 0001164888 KBPH:HealionicsCorporationMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAOnePreferredMember 2021-04-01 2021-12-31 0001164888 KBPH:ILumenScientificIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAPreferredPlusWarrantsMember 2021-04-01 2021-12-31 0001164888 KBPH:ILumenScientificIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAPreferredPlusWarrantsOneMember 2021-04-01 2021-12-31 0001164888 KBPH:InhalonBiopharmaIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredMember 2021-04-01 2021-12-31 0001164888 KBPH:KitotechMedicalIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesBPreferredMember 2021-04-01 2021-12-31 0001164888 KBPH:LightLineMedicalIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredConvertedNoteMember 2021-04-01 2021-12-31 0001164888 KBPH:LightLineMedicalIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredConvertedNoteOneMember 2021-04-01 2021-12-31 0001164888 KBPH:LightLineMedicalIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredMember 2021-04-01 2021-12-31 0001164888 KBPH:LightLineMedicalIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAPreferredPlusWarrantsMember 2021-04-01 2021-12-31 0001164888 KBPH:LowellTherapeuticsIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesAPreferredStockMember 2021-04-01 2021-12-31 0001164888 KBPH:LowellTherapeuticsIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAPreferredStockOneMember 2021-04-01 2021-12-31 0001164888 KBPH:LowellTherapeuticsIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesBPreferredStockMember 2021-04-01 2021-12-31 0001164888 KBPH:MakaniScienceIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredMember 2021-04-01 2021-12-31 0001164888 KBPH:MicronicTechnologiesIncMember KBPH:TechnologyMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedOnePreferredPlusWarrantsMember 2021-04-01 2021-12-31 0001164888 KBPH:MicronicTechnologiesIncMember KBPH:TechnologyMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredPlusWarrantsMember 2021-04-01 2021-12-31 0001164888 KBPH:NeuroflowIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedTwoPreferredMember 2021-04-01 2021-12-31 0001164888 KBPH:NeuroflowIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesBPreferredStockMember 2021-04-01 2021-12-31 0001164888 KBPH:NewViewSurgicalIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAOnePreferredMember 2021-04-01 2021-12-31 0001164888 KBPH:NewViewSurgicalIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAOnePreferredOneMember 2021-04-01 2021-12-31 0001164888 KBPH:OrionBiotechnologyIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesAPreferredStockMember 2021-04-01 2021-12-31 0001164888 KBPH:OtomagneticsIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAOnePreferredPlusWarrantsMember 2021-04-01 2021-12-31 0001164888 KBPH:PartheousIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesAPreferredStockMember 2021-04-01 2021-12-31 0001164888 KBPH:PromaxoIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesBOnePreferredConvertedNoteMember 2021-04-01 2021-12-31 0001164888 KBPH:SageMedicCorpMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredConvertedNoteMember 2021-04-01 2021-12-31 0001164888 KBPH:SealRockTherapeuticsIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredConvertedNoteMember 2021-04-01 2021-12-31 0001164888 KBPH:ShyftFKACraterGroupIncMember KBPH:TechnologyMember KBPH:PreferredInvestmentsMember KBPH:SeriesAOnePreferredMember 2021-04-01 2021-12-31 0001164888 KBPH:ShyftFKACraterGroupIncMember KBPH:TechnologyMember KBPH:PreferredInvestmentsMember KBPH:SeriesAPreferredConvertedNoteMember 2021-04-01 2021-12-31 0001164888 KBPH:ShyftFKACraterGroupIncMember KBPH:TechnologyMember KBPH:PreferredInvestmentsMember KBPH:SeriesAOnePreferredConvertedNoteMember 2021-04-01 2021-12-31 0001164888 KBPH:TrellisBioscienceLLCMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesBPreferredPlusWarrantsMember 2021-04-01 2021-12-31 0001164888 KBPH:TrellisBioscienceLLCMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesBPreferredPlusWarrantsOneMember 2021-04-01 2021-12-31 0001164888 KBPH:TrellisBioscienceLLCMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesBPreferredPlusWarrantsTwoMember 2021-04-01 2021-12-31 0001164888 KBPH:TrioLabsIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredMember 2021-04-01 2021-12-31 0001164888 KBPH:ValfixMedicalIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredMember 2021-04-01 2021-12-31 0001164888 KBPH:VesteckIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAPreferredConvertedNoteMember 2021-04-01 2021-12-31 0001164888 KBPH:VisgenxIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedOnePreferredConvertedNoteMember 2021-04-01 2021-12-31 0001164888 KBPH:VisgenxIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredConvertedNoteMember 2021-04-01 2021-12-31 0001164888 KBPH:VisgenxIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredConvertedNoteOneMember 2021-04-01 2021-12-31 0001164888 KBPH:BendaRXCorpMember KBPH:LifeScienceMember KBPH:CommonStockInvestmentsMember us-gaap:CommonStockMember 2021-04-01 2021-12-31 0001164888 KBPH:BendaRXCorpMember KBPH:LifeScienceMember KBPH:CommonStockInvestmentsMember KBPH:CommonStockOneMember 2021-04-01 2021-12-31 0001164888 KBPH:KuantsolIncMember KBPH:TechnologyMember KBPH:CommonStockInvestmentsMember us-gaap:CommonStockMember 2021-04-01 2021-12-31 0001164888 KBPH:BoardwalkTechMember KBPH:TechnologyMember KBPH:PublicCommonStockInvestmentsMember us-gaap:CommonStockMember 2021-04-01 2021-12-31 0001164888 KBPH:BoardwalkTechMember KBPH:TechnologyMember KBPH:PublicCommonStockInvestmentsMember KBPH:CommonStockOneMember 2021-04-01 2021-12-31 0001164888 KBPH:SanabyHealthAcquisitionCorpOneMember KBPH:LifeScienceMember KBPH:CommonStockInvestmentsMember us-gaap:CommonStockMember 2021-04-01 2021-12-31 0001164888 KBPH:EnduralockLLCMember KBPH:TechnologyMember KBPH:OtherInvestmentMember KBPH:SeriesAOneOwnershipUnitsMember 2021-04-01 2021-12-31 0001164888 KBPH:EnduralockLLCMember KBPH:TechnologyMember KBPH:OtherInvestmentMember KBPH:SeriesAOneOwnershipUnitsOneMember 2021-04-01 2021-12-31 0001164888 KBPH:GreenSunMedicalLLCMember KBPH:LifeScienceMember KBPH:OtherInvestmentMember KBPH:ClassAOnePreferredOwnershipUnitsMember 2021-04-01 2021-12-31 0001164888 KBPH:GreenSunMedicalLLCMember KBPH:LifeScienceMember KBPH:OtherInvestmentMember KBPH:ClassAOnePreferredOwnershipUnitsOneMember 2021-04-01 2021-12-31 0001164888 KBPH:GreenSunMedicalLLCMember KBPH:LifeScienceMember KBPH:OtherInvestmentMember KBPH:ClassAOnePreferredOwnershipUnitsTwoMember 2021-04-01 2021-12-31 0001164888 KBPH:GreenSunMedicalLLCMember KBPH:LifeScienceMember KBPH:OtherInvestmentMember KBPH:ClassAOnePreferredOwnershipUnitsThreeMember 2021-04-01 2021-12-31 0001164888 KBPH:AcheliosTherapeuticsIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageDueDecemeberTwoThousandTwentyOneMember 2020-04-01 2021-03-31 0001164888 KBPH:AcheliosTherapeuticsIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageDueDecemeberTwoThousandTwentyOneOneMember 2020-04-01 2021-03-31 0001164888 KBPH:AcheliosTherapeuticsIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageDueDecemeberTwoThousandTwentyOneTwoMember 2020-04-01 2021-03-31 0001164888 KBPH:AvisiTechnologiesIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageDueJulyTwoThousandTwentyTwoMember 2020-04-01 2021-03-31 0001164888 KBPH:BasepawsIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteOnePercentageDueAprilTwoThousandTwentyMember 2020-04-01 2021-03-31 0001164888 KBPH:BeamSemiConductorIncMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageDueAprilTwoThousandTwentyTwoMember 2020-04-01 2021-03-31 0001164888 KBPH:BeamSemiConductorIncMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageDueMarchTwoThousandTwentyOneMember 2020-04-01 2021-03-31 0001164888 KBPH:CorinnovaIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSixPercentageDueDecemberTwoThousandTwentyFourMember 2020-04-01 2021-03-31 0001164888 KBPH:CyberdonticsIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageDueSeptemberTwoThousandTwentyTwoMember 2020-04-01 2021-03-31 0001164888 KBPH:CyberdonticsIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageDueFebruaryTwoThousandTwentyThreeMember 2020-04-01 2021-03-31 0001164888 KBPH:DeepBlueMedicalAdvancesIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSixPercentageDueJuneTwoThousandTwentyTwoMember 2020-04-01 2021-03-31 0001164888 KBPH:EveryKeyIncMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteFivePercentageDueDecemberTwoThousandTwentyThreeMember 2020-04-01 2021-03-31 0001164888 KBPH:IdenticalIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteTwoPercentageDueMayTwoThousandTwentyTwoMember 2020-04-01 2021-03-31 0001164888 KBPH:INBayTechnonlogyIncMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteTwelvePercentageDueOctoberTwoThousandTwentyMember 2020-04-01 2021-03-31 0001164888 KBPH:INBayTechnonlogyIncMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteTwelvePercentageDueJulyTwoThousandTwentyOneMember 2020-04-01 2021-03-31 0001164888 KBPH:INBayTechnonlogyIncMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteTwelvePercentageDueFebruaryTwoThousandTwentyTwoMember 2020-04-01 2021-03-31 0001164888 KBPH:INBayTechnonlogyIncMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteTwelvePercentageDueDecemberTwoThousandTwentyTwoMember 2020-04-01 2021-03-31 0001164888 KBPH:KianaAnalyticsMember KBPH:TechnologyMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteThreePercentageDueDecemberTwoThousandTwentyTwoMember 2020-04-01 2021-03-31 0001164888 KBPH:KiotechMedicalIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSixPercentageDueDecemberTwoThousandTwentyMember 2020-04-01 2021-03-31 0001164888 KBPH:KiotechMedicalIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSixPercentageDueNovemberTwoThousandTwentyTwoMember 2020-04-01 2021-03-31 0001164888 KBPH:LifewaveBiomedicalIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSixPercentageDueDecemberTwoThousandTwentyMember 2020-04-01 2021-03-31 0001164888 KBPH:LifewaveBiomedicalIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSixPercentageDueDecemberTwoThousandTwentyOnlyMember 2020-04-01 2021-03-31 0001164888 KBPH:NavauxIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSixPercentageDueDecemberTwoThousandTwentyThreeMember 2020-04-01 2021-03-31 0001164888 KBPH:NeuroFoutyTwoIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageDueDecemberTwoThousandTwentyThreeMember 2020-04-01 2021-03-31 0001164888 KBPH:OctagonTherapeuticsIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteFivePercentageDueJuneTwoThousandTwentyOneMember 2020-04-01 2021-03-31 0001164888 KBPH:OctagonTherapeuticsIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteFivePercentageDueJuneTwoThousandTwentyOneOnlyMember 2020-04-01 2021-03-31 0001164888 KBPH:PerikineticsIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSixPercentageDueMayTwoThousandTwentyTwoMember 2020-04-01 2021-03-31 0001164888 KBPH:PreviewMedicalIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteSevenPercentageDueJanuaryTwoThousandTwentyThreeMember 2020-04-01 2021-03-31 0001164888 KBPH:SageMedicCorpMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageDueAprilTwoThousandTwentyOnePlusWarrantsMember 2020-04-01 2021-03-31 0001164888 KBPH:SageMedicCorpMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageDueDecemberTwoThousandTwentyTwoPlusWarrantsMember 2020-04-01 2021-03-31 0001164888 KBPH:ValfixMedicalIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageDecemberTwoThousandTwentyOneMember 2020-04-01 2021-03-31 0001164888 KBPH:XpanIncMember KBPH:LifeScienceMember us-gaap:CorporateNoteSecuritiesMember KBPH:ConvertibleNoteEightPercentageMarchTwoThousandTwentyTwoMember 2020-04-01 2021-03-31 0001164888 KBPH:XpanIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageJuneTwoThousandTwentyTwoMember 2020-04-01 2021-03-31 0001164888 KBPH:XpanIncMember KBPH:LifeScienceMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:ConvertibleNoteEightPercentageJuneTwoThousandTwentyTwoOnlyMember 2020-04-01 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredMember KBPH:AltisBiosystemsMember 2020-04-01 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesAPreferredStockMember KBPH:AstrocytePharmaceuticalsIncMember 2020-04-01 2021-03-31 0001164888 KBPH:FintechMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedTwoPreferredMember KBPH:CnoteGroupIncMember 2020-04-01 2021-03-31 0001164888 KBPH:FintechMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedThreePreferredMember KBPH:CnoteGroupIncMember 2020-04-01 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAOnePreferredMember KBPH:ColabsIncMember 2020-04-01 2021-03-31 0001164888 KBPH:TechnologyMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredMember KBPH:ConnectusServicesLtdMember 2020-04-01 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesAPreferredStockMember KBPH:DeepBlueMedicalAdvancesIncMember 2020-04-01 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesAPreferredStockMember KBPH:EumentisThereapeuticsIncMember 2020-04-01 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesAPreferredStockMember KBPH:FemtoDXIncMember 2020-04-01 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAPreferredPlusWarrantsMember KBPH:ILumenScientificIncMember 2020-04-01 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAPreferredPlusWarrantsOneMember KBPH:ILumenScientificIncMember 2020-04-01 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredMember KBPH:InhalonBiopharmaIncMember 2020-04-01 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredConvertedNoteMember KBPH:LightLineMedicalIncMember 2020-04-01 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredConvertedNoteOneMember KBPH:LightLineMedicalIncMember 2020-04-01 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredMember KBPH:LightLineMedicalIncMember 2020-04-01 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAPreferredPlusWarrantsMember KBPH:LightLineMedicalIncMember 2020-04-01 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesAPreferredStockMember KBPH:LowellTherapeuticsIncMember 2020-04-01 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAPreferredStockOneMember KBPH:LowellTherapeuticsIncMember 2020-04-01 2021-03-31 0001164888 KBPH:TechnologyMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedOnePreferredPlusWarrantsMember KBPH:MicronicTechnologiesIncMember 2020-04-01 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedTwoPreferredMember KBPH:NeuroflowIncMember 2020-04-01 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember us-gaap:SeriesBPreferredStockMember KBPH:NeuroflowIncMember 2020-04-01 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAOnePreferredMember KBPH:NewViewSurgicalIncMember 2020-04-01 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesAOnePreferredPlusWarrantsMember KBPH:OtomagneticsIncMember 2020-04-01 2021-03-31 0001164888 KBPH:PromaxoIncMember KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesBOnePreferredConvertedNoteMember 2020-04-01 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredConvertedNoteMember KBPH:SealRockTherapeuticsIncMember 2020-04-01 2021-03-31 0001164888 KBPH:TechnologyMember KBPH:PreferredInvestmentsMember KBPH:SeriesAOnePreferredMember KBPH:ShyftFKACraterGroupIncMember 2020-04-01 2021-03-31 0001164888 KBPH:TechnologyMember KBPH:PreferredInvestmentsMember KBPH:SeriesAPreferredConvertedNoteMember KBPH:ShyftFKACraterGroupIncMember 2020-04-01 2021-03-31 0001164888 KBPH:TechnologyMember KBPH:PreferredInvestmentsMember KBPH:SeriesAOnePreferredConvertedNoteMember KBPH:ShyftFKACraterGroupIncMember 2020-04-01 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesBPreferredPlusWarrantsMember KBPH:TrellisBioscienceLLCMember 2020-04-01 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesBPreferredPlusWarrantsOneMember KBPH:TrellisBioscienceLLCMember 2020-04-01 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesBPreferredPlusWarrantsTwoMember KBPH:TrellisBioscienceLLCMember 2020-04-01 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredMember KBPH:ValfixMedicalIncMember 2020-04-01 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedOnePreferredConvertedNoteMember KBPH:VisgenxIncMember 2020-04-01 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredConvertedNoteMember KBPH:VisgenxIncMember 2020-04-01 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:PreferredInvestmentsMember KBPH:SeriesSeedPreferredConvertedNoteOneMember KBPH:VisgenxIncMember 2020-04-01 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:CommonStockInvestmentsMember us-gaap:CommonStockMember KBPH:BendaRXCorpMember 2020-04-01 2021-03-31 0001164888 KBPH:LifeScienceMember KBPH:CommonStockInvestmentsMember KBPH:CommonStockOneMember KBPH:BendaRXCorpMember 2020-04-01 2021-03-31 0001164888 KBPH:BoardwalkTechMember KBPH:TechnologyMember KBPH:CommonStockInvestmentsMember us-gaap:CommonStockMember 2020-04-01 2021-03-31 0001164888 KBPH:SeriesAOneOwnershipUnitsMember KBPH:TechnologyMember KBPH:OtherInvestmentMember KBPH:EnduralockLLCMember 2020-04-01 2021-03-31 0001164888 KBPH:SeriesAOneOwnershipUnitsOneMember KBPH:TechnologyMember KBPH:OtherInvestmentMember KBPH:EnduralockLLCMember 2020-04-01 2021-03-31 0001164888 KBPH:ClassAOnePreferredOwnershipUnitsMember KBPH:LifeScienceMember KBPH:OtherInvestmentMember KBPH:GreenSunMedicalLLCMember 2020-04-01 2021-03-31 0001164888 KBPH:ClassAOnePreferredOwnershipUnitsOneMember KBPH:LifeScienceMember KBPH:OtherInvestmentMember KBPH:GreenSunMedicalLLCMember 2020-04-01 2021-03-31 0001164888 KBPH:ClassAOnePreferredOwnershipUnitsTwoMember KBPH:LifeScienceMember KBPH:OtherInvestmentMember KBPH:GreenSunMedicalLLCMember 2020-04-01 2021-03-31 0001164888 2018-03-31 0001164888 srt:MaximumMember 2021-12-31 0001164888 srt:ChiefExecutiveOfficerMember 2021-01-01 2021-01-02 0001164888 srt:ChiefExecutiveOfficerMember 2021-10-01 2021-12-31 0001164888 srt:ChiefExecutiveOfficerMember 2021-04-01 2021-12-31 0001164888 srt:ChiefExecutiveOfficerMember 2021-12-31 0001164888 srt:ChiefExecutiveOfficerMember 2020-10-01 2020-12-31 0001164888 srt:ChiefExecutiveOfficerMember 2020-04-01 2020-12-31 0001164888 srt:RestatementAdjustmentMember 2021-07-01 2021-09-30 0001164888 srt:RestatementAdjustmentMember 2021-04-01 2021-09-30 0001164888 srt:RestatementAdjustmentMember 2021-04-01 2021-06-30 0001164888 KBPH:ConsultantsAndAdvisorsMember 2021-10-01 2021-12-31 0001164888 KBPH:ConsultantsAndAdvisorsMember 2020-10-01 2020-12-31 0001164888 KBPH:ConsultantsAndAdvisorsMember 2021-04-01 2021-12-31 0001164888 KBPH:ConsultantsAndAdvisorsMember 2020-04-01 2020-12-31 0001164888 srt:ScenarioPreviouslyReportedMember 2021-07-01 2021-09-30 0001164888 srt:ScenarioPreviouslyReportedMember 2021-04-01 2021-06-30 0001164888 srt:ScenarioPreviouslyReportedMember 2021-04-01 2021-09-30 0001164888 2021-07-01 2021-09-30 0001164888 2021-04-01 2021-06-30 0001164888 2021-04-01 2021-09-30 0001164888 us-gaap:CommonStockMember 2021-10-01 2021-12-31 0001164888 us-gaap:CommonStockMember 2021-04-01 2021-12-31 0001164888 us-gaap:SeriesAPreferredStockMember 2021-10-01 2021-12-31 0001164888 us-gaap:SeriesAPreferredStockMember 2021-04-01 2021-12-31 0001164888 us-gaap:SeriesBPreferredStockMember 2021-10-01 2021-12-31 0001164888 us-gaap:SeriesBPreferredStockMember 2021-04-01 2021-12-31 0001164888 us-gaap:EmployeeStockOptionMember 2021-10-01 2021-12-31 0001164888 us-gaap:EmployeeStockOptionMember 2021-04-01 2021-12-31 0001164888 us-gaap:WarrantMember 2021-10-01 2021-12-31 0001164888 us-gaap:WarrantMember 2021-04-01 2021-12-31 0001164888 us-gaap:CommonStockMember 2020-10-01 2020-12-31 0001164888 us-gaap:CommonStockMember 2020-04-01 2020-12-31 0001164888 us-gaap:SeriesAPreferredStockMember 2020-10-01 2020-12-31 0001164888 us-gaap:SeriesAPreferredStockMember 2020-04-01 2020-12-31 0001164888 us-gaap:SeriesBPreferredStockMember 2020-10-01 2020-12-31 0001164888 us-gaap:SeriesBPreferredStockMember 2020-04-01 2020-12-31 0001164888 us-gaap:EmployeeStockOptionMember 2020-10-01 2020-12-31 0001164888 us-gaap:EmployeeStockOptionMember 2020-04-01 2020-12-31 0001164888 us-gaap:WarrantMember 2020-10-01 2020-12-31 0001164888 us-gaap:WarrantMember 2020-04-01 2020-12-31 0001164888 KBPH:ConvertibleNotesMember 2021-12-31 0001164888 KBPH:ConvertibleNotesMember 2021-03-31 0001164888 KBPH:PreferredStockFairValueMember 2021-12-31 0001164888 KBPH:PreferredStockFairValueMember 2021-03-31 0001164888 us-gaap:PreferredStockMember 2021-03-31 0001164888 us-gaap:CommonStockMember 2021-12-31 0001164888 us-gaap:CommonStockMember 2021-03-31 0001164888 KBPH:SafeMember 2021-12-31 0001164888 KBPH:SafeMember 2021-03-31 0001164888 KBPH:OtherOwnershipUnitsMember 2021-12-31 0001164888 KBPH:OtherOwnershipUnitsMember 2021-03-31 0001164888 KBPH:InvestmentFairValueMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:BasepawsIncMember 2021-12-31 0001164888 KBPH:InvestmentFairValueMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:BasepawsIncMember 2021-04-01 2021-12-31 0001164888 KBPH:InvestmentFairValueMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:CyberdonticsIncMember 2021-12-31 0001164888 KBPH:InvestmentFairValueMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:CyberdonticsIncMember 2021-04-01 2021-12-31 0001164888 KBPH:InvestmentFairValueMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:PromaxoIncMember 2021-12-31 0001164888 KBPH:InvestmentFairValueMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:PromaxoIncMember 2021-04-01 2021-12-31 0001164888 srt:WeightedAverageMember KBPH:PromaxoIncMember KBPH:InvestmentFairValueMember us-gaap:ConvertibleDebtSecuritiesMember 2021-12-31 0001164888 KBPH:InvestmentFairValueMember KBPH:ConvertibleDebtSecuritiesOtherMember 2021-12-31 0001164888 KBPH:InvestmentFairValueMember KBPH:ConvertibleDebtSecuritiesOtherMember 2021-04-01 2021-12-31 0001164888 srt:MinimumMember KBPH:InvestmentFairValueMember KBPH:ConvertibleDebtSecuritiesOtherMember 2021-12-31 0001164888 srt:MaximumMember KBPH:InvestmentFairValueMember KBPH:ConvertibleDebtSecuritiesOtherMember 2021-12-31 0001164888 KBPH:InvestmentFairValueMember KBPH:PreferredStockInPrivateCompaniesMember KBPH:InhalonIncMember 2021-12-31 0001164888 KBPH:InvestmentFairValueMember KBPH:PreferredStockInPrivateCompaniesMember KBPH:InhalonIncMember 2021-04-01 2021-12-31 0001164888 KBPH:InvestmentFairValueMember KBPH:PreferredStockInPrivateCompaniesMember KBPH:NeuroflowIncMember 2021-12-31 0001164888 KBPH:InvestmentFairValueMember KBPH:PreferredStockInPrivateCompaniesMember KBPH:NeuroflowIncMember 2021-04-01 2021-12-31 0001164888 KBPH:InvestmentFairValueMember KBPH:PreferredStockInPrivateCompaniesMember KBPH:ValfixIncMember 2021-12-31 0001164888 KBPH:InvestmentFairValueMember KBPH:PreferredStockInPrivateCompaniesMember KBPH:ValfixIncMember 2021-04-01 2021-12-31 0001164888 KBPH:InvestmentFairValueMember KBPH:PreferredStockInPrivateCompaniesMember KBPH:ShyftMovingIncMember 2021-12-31 0001164888 KBPH:InvestmentFairValueMember KBPH:PreferredStockInPrivateCompaniesMember KBPH:ShyftMovingIncMember 2021-04-01 2021-12-31 0001164888 KBPH:InvestmentFairValueMember KBPH:PreferredStockInPrivateCompaniesMember KBPH:SealRockTherapeuticsIncMember 2021-12-31 0001164888 KBPH:InvestmentFairValueMember KBPH:PreferredStockInPrivateCompaniesMember KBPH:SealRockTherapeuticsIncMember 2021-04-01 2021-12-31 0001164888 KBPH:InvestmentFairValueMember KBPH:PreferredStockInPrivateCompaniesMember KBPH:FemtoDXIncMember 2021-12-31 0001164888 KBPH:InvestmentFairValueMember KBPH:PreferredStockInPrivateCompaniesMember KBPH:FemtoDXIncMember 2021-04-01 2021-12-31 0001164888 KBPH:InvestmentFairValueMember KBPH:PreferredStockInPrivateCompaniesMember KBPH:PromaxoIncMember 2021-12-31 0001164888 KBPH:InvestmentFairValueMember KBPH:PreferredStockInPrivateCompaniesMember KBPH:PromaxoIncMember 2021-04-01 2021-12-31 0001164888 srt:MinimumMember KBPH:InvestmentFairValueMember KBPH:PreferredStockInPrivateCompaniesMember KBPH:PromaxoIncMember 2021-12-31 0001164888 srt:MaximumMember KBPH:InvestmentFairValueMember KBPH:PreferredStockInPrivateCompaniesMember KBPH:PromaxoIncMember 2021-12-31 0001164888 KBPH:InvestmentFairValueMember KBPH:PreferredStockInPrivateCompaniesOtherMember 2021-12-31 0001164888 KBPH:InvestmentFairValueMember KBPH:PreferredStockInPrivateCompaniesOtherMember 2021-04-01 2021-12-31 0001164888 KBPH:InvestmentFairValueMember KBPH:CommonStockInPrivateCompaniesMember 2021-12-31 0001164888 KBPH:InvestmentFairValueMember KBPH:CommonStockInPrivateCompaniesMember 2021-04-01 2021-12-31 0001164888 KBPH:InvestmentFairValueMember KBPH:SafeMember 2021-12-31 0001164888 KBPH:InvestmentFairValueMember KBPH:SafeMember 2021-04-01 2021-12-31 0001164888 KBPH:InvestmentFairValueMember 2021-12-31 0001164888 KBPH:InvestmentFairValueMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:KitotechMedicalIncMember 2021-03-31 0001164888 KBPH:InvestmentFairValueMember us-gaap:ConvertibleDebtSecuritiesMember KBPH:KitotechMedicalIncMember 2020-04-01 2021-03-31 0001164888 KBPH:InvestmentFairValueMember us-gaap:ConvertibleDebtSecuritiesMember 2021-03-31 0001164888 KBPH:InvestmentFairValueMember us-gaap:ConvertibleDebtSecuritiesMember 2020-04-01 2021-03-31 0001164888 srt:MinimumMember KBPH:InvestmentFairValueMember us-gaap:ConvertibleDebtSecuritiesMember 2021-03-31 0001164888 srt:MaximumMember KBPH:InvestmentFairValueMember us-gaap:ConvertibleDebtSecuritiesMember 2021-03-31 0001164888 KBPH:InvestmentFairValueMember KBPH:PreferredStockInPrivateCompaniesMember KBPH:FemtoDXIncMember 2021-03-31 0001164888 KBPH:InvestmentFairValueMember KBPH:PreferredStockInPrivateCompaniesMember KBPH:FemtoDXIncMember 2020-04-01 2021-03-31 0001164888 KBPH:InvestmentFairValueMember KBPH:PreferredStockInPrivateCompaniesMember KBPH:NeuroflowIncMember 2021-03-31 0001164888 KBPH:InvestmentFairValueMember KBPH:PreferredStockInPrivateCompaniesMember KBPH:NeuroflowIncMember 2020-04-01 2021-03-31 0001164888 KBPH:InvestmentFairValueMember KBPH:PreferredStockInPrivateCompaniesOtherMember 2021-03-31 0001164888 KBPH:InvestmentFairValueMember KBPH:PreferredStockInPrivateCompaniesOtherMember 2020-04-01 2021-03-31 0001164888 KBPH:InvestmentFairValueMember KBPH:CommonStockInPrivateCompaniesMember 2021-03-31 0001164888 KBPH:InvestmentFairValueMember KBPH:CommonStockInPrivateCompaniesMember 2020-04-01 2021-03-31 0001164888 KBPH:InvestmentFairValueMember KBPH:SafeMember 2021-03-31 0001164888 KBPH:InvestmentFairValueMember KBPH:SafeMember 2020-04-01 2021-03-31 0001164888 KBPH:InvestmentFairValueMember us-gaap:OtherInvestmentsMember 2021-03-31 0001164888 KBPH:InvestmentFairValueMember us-gaap:OtherInvestmentsMember 2020-04-01 2021-03-31 0001164888 KBPH:InvestmentFairValueMember 2021-03-31 0001164888 us-gaap:FairValueInputsLevel1Member us-gaap:ConvertibleDebtSecuritiesMember 2021-12-31 0001164888 us-gaap:FairValueInputsLevel2Member us-gaap:ConvertibleDebtSecuritiesMember 2021-12-31 0001164888 us-gaap:FairValueInputsLevel3Member us-gaap:ConvertibleDebtSecuritiesMember 2021-12-31 0001164888 us-gaap:FairValueInputsLevel1Member KBPH:PreferredStockInPrivateCompaniesMember 2021-12-31 0001164888 us-gaap:FairValueInputsLevel2Member KBPH:PreferredStockInPrivateCompaniesMember 2021-12-31 0001164888 us-gaap:FairValueInputsLevel3Member KBPH:PreferredStockInPrivateCompaniesMember 2021-12-31 0001164888 KBPH:PreferredStockInPrivateCompaniesMember 2021-12-31 0001164888 us-gaap:FairValueInputsLevel1Member KBPH:CommonStockInPrivateCompaniesMember 2021-12-31 0001164888 us-gaap:FairValueInputsLevel2Member KBPH:CommonStockInPrivateCompaniesMember 2021-12-31 0001164888 us-gaap:FairValueInputsLevel3Member KBPH:CommonStockInPrivateCompaniesMember 2021-12-31 0001164888 KBPH:CommonStockInPrivateCompaniesMember 2021-12-31 0001164888 us-gaap:FairValueInputsLevel1Member KBPH:SafeMember 2021-12-31 0001164888 us-gaap:FairValueInputsLevel2Member KBPH:SafeMember 2021-12-31 0001164888 us-gaap:FairValueInputsLevel3Member KBPH:SafeMember 2021-12-31 0001164888 us-gaap:FairValueInputsLevel1Member KBPH:PrivatePortfolioCompaniesMember 2021-12-31 0001164888 us-gaap:FairValueInputsLevel2Member KBPH:PrivatePortfolioCompaniesMember 2021-12-31 0001164888 us-gaap:FairValueInputsLevel3Member KBPH:PrivatePortfolioCompaniesMember 2021-12-31 0001164888 KBPH:PrivatePortfolioCompaniesMember 2021-12-31 0001164888 us-gaap:FairValueInputsLevel1Member KBPH:CommonStockInPublicCompaniesMember 2021-12-31 0001164888 us-gaap:FairValueInputsLevel2Member KBPH:CommonStockInPublicCompaniesMember 2021-12-31 0001164888 us-gaap:FairValueInputsLevel3Member KBPH:CommonStockInPublicCompaniesMember 2021-12-31 0001164888 KBPH:CommonStockInPublicCompaniesMember 2021-12-31 0001164888 us-gaap:FairValueInputsLevel1Member 2021-12-31 0001164888 us-gaap:FairValueInputsLevel2Member 2021-12-31 0001164888 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001164888 us-gaap:FairValueInputsLevel1Member us-gaap:ConvertibleDebtSecuritiesMember 2021-03-31 0001164888 us-gaap:FairValueInputsLevel2Member us-gaap:ConvertibleDebtSecuritiesMember 2021-03-31 0001164888 us-gaap:FairValueInputsLevel3Member us-gaap:ConvertibleDebtSecuritiesMember 2021-03-31 0001164888 us-gaap:FairValueInputsLevel1Member KBPH:PreferredStockInPrivateCompaniesMember 2021-03-31 0001164888 us-gaap:FairValueInputsLevel2Member KBPH:PreferredStockInPrivateCompaniesMember 2021-03-31 0001164888 us-gaap:FairValueInputsLevel3Member KBPH:PreferredStockInPrivateCompaniesMember 2021-03-31 0001164888 KBPH:PreferredStockInPrivateCompaniesMember 2021-03-31 0001164888 us-gaap:FairValueInputsLevel1Member KBPH:CommonStockInPrivateCompaniesMember 2021-03-31 0001164888 us-gaap:FairValueInputsLevel2Member KBPH:CommonStockInPrivateCompaniesMember 2021-03-31 0001164888 us-gaap:FairValueInputsLevel3Member KBPH:CommonStockInPrivateCompaniesMember 2021-03-31 0001164888 KBPH:CommonStockInPrivateCompaniesMember 2021-03-31 0001164888 us-gaap:FairValueInputsLevel1Member KBPH:SafeMember 2021-03-31 0001164888 us-gaap:FairValueInputsLevel2Member KBPH:SafeMember 2021-03-31 0001164888 us-gaap:FairValueInputsLevel3Member KBPH:SafeMember 2021-03-31 0001164888 us-gaap:FairValueInputsLevel1Member us-gaap:OtherInvestmentsMember 2021-03-31 0001164888 us-gaap:FairValueInputsLevel2Member us-gaap:OtherInvestmentsMember 2021-03-31 0001164888 us-gaap:FairValueInputsLevel3Member us-gaap:OtherInvestmentsMember 2021-03-31 0001164888 us-gaap:OtherInvestmentsMember 2021-03-31 0001164888 us-gaap:FairValueInputsLevel1Member KBPH:PrivatePortfolioCompaniesMember 2021-03-31 0001164888 us-gaap:FairValueInputsLevel2Member KBPH:PrivatePortfolioCompaniesMember 2021-03-31 0001164888 us-gaap:FairValueInputsLevel3Member KBPH:PrivatePortfolioCompaniesMember 2021-03-31 0001164888 KBPH:PrivatePortfolioCompaniesMember 2021-03-31 0001164888 us-gaap:FairValueInputsLevel1Member KBPH:CommonStockInPublicCompaniesMember 2021-03-31 0001164888 us-gaap:FairValueInputsLevel2Member KBPH:CommonStockInPublicCompaniesMember 2021-03-31 0001164888 us-gaap:FairValueInputsLevel3Member KBPH:CommonStockInPublicCompaniesMember 2021-03-31 0001164888 KBPH:CommonStockInPublicCompaniesMember 2021-03-31 0001164888 us-gaap:FairValueInputsLevel1Member 2021-03-31 0001164888 us-gaap:FairValueInputsLevel2Member 2021-03-31 0001164888 us-gaap:FairValueInputsLevel3Member 2021-03-31 0001164888 country:US 2021-04-01 2021-12-31 0001164888 country:CA 2021-04-01 2021-12-31 0001164888 KBPH:RestOfWorldMember 2021-04-01 2021-12-31 0001164888 country:US 2020-03-31 0001164888 country:CA 2020-03-31 0001164888 KBPH:RestOfWorldMember 2020-03-31 0001164888 country:US 2020-04-01 2020-12-31 0001164888 country:CA 2020-04-01 2020-12-31 0001164888 KBPH:RestOfWorldMember 2020-04-01 2020-12-31 0001164888 country:US 2020-12-31 0001164888 country:CA 2020-12-31 0001164888 KBPH:RestOfWorldMember 2020-12-31 0001164888 KBPH:FintechMember 2021-03-31 0001164888 KBPH:TechnologyMember 2021-03-31 0001164888 KBPH:LifeScienceMember 2021-03-31 0001164888 KBPH:FintechMember 2021-04-01 2021-12-31 0001164888 KBPH:TechnologyMember 2021-04-01 2021-12-31 0001164888 KBPH:LifeScienceMember 2021-04-01 2021-12-31 0001164888 KBPH:FintechMember 2021-12-31 0001164888 KBPH:TechnologyMember 2021-12-31 0001164888 KBPH:LifeScienceMember 2021-12-31 0001164888 KBPH:FintechMember 2020-03-31 0001164888 KBPH:TechnologyMember 2020-03-31 0001164888 KBPH:LifeScienceMember 2020-03-31 0001164888 KBPH:FintechMember 2020-04-01 2020-12-31 0001164888 KBPH:TechnologyMember 2020-04-01 2020-12-31 0001164888 KBPH:LifeScienceMember 2020-04-01 2020-12-31 0001164888 KBPH:FintechMember 2020-12-31 0001164888 KBPH:TechnologyMember 2020-12-31 0001164888 KBPH:LifeScienceMember 2020-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember 2021-04-01 2021-12-31 0001164888 us-gaap:PreferredStockMember 2021-04-01 2021-12-31 0001164888 us-gaap:CommonStockMember 2021-04-01 2021-12-31 0001164888 KBPH:SafeMember 2021-04-01 2021-12-31 0001164888 KBPH:OtherOwnershipUnitsMember 2021-04-01 2021-12-31 0001164888 us-gaap:PreferredStockMember 2021-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember 2020-03-31 0001164888 us-gaap:PreferredStockMember 2020-03-31 0001164888 us-gaap:CommonStockMember 2020-03-31 0001164888 KBPH:SafeMember 2020-03-31 0001164888 KBPH:OtherOwnershipUnitsMember 2020-03-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember 2020-04-01 2020-12-31 0001164888 us-gaap:PreferredStockMember 2020-04-01 2020-12-31 0001164888 us-gaap:CommonStockMember 2020-04-01 2020-12-31 0001164888 KBPH:SafeMember 2020-04-01 2020-12-31 0001164888 KBPH:OtherOwnershipUnitsMember 2020-04-01 2020-12-31 0001164888 us-gaap:ConvertibleDebtSecuritiesMember 2020-12-31 0001164888 us-gaap:PreferredStockMember 2020-12-31 0001164888 us-gaap:CommonStockMember 2020-12-31 0001164888 KBPH:SafeMember 2020-12-31 0001164888 KBPH:OtherOwnershipUnitsMember 2020-12-31 0001164888 us-gaap:SeriesAPreferredStockMember 2021-04-01 2021-12-31 0001164888 KBPH:SeriesAOnePreferredStockMember 2021-03-02 0001164888 KBPH:SeriesAOnePreferredStockMember 2021-02-28 2021-03-02 0001164888 KBPH:SeriesAOneAndSeriesATwoPreferredStockMember us-gaap:IPOMember 2021-04-01 2021-12-31 0001164888 KBPH:SeriesAOnePreferredStockMember 2021-04-01 2021-12-31 0001164888 KBPH:SeriesATwoPreferredStockMember 2021-04-01 2021-12-31 0001164888 us-gaap:CommonStockMember us-gaap:SeriesBPreferredStockMember 2021-03-02 0001164888 KBPH:SeriesBOnePreferredStockMember 2021-02-28 2021-03-02 0001164888 KBPH:SeriesBOneAndSeriesBTwoPreferredStockMember us-gaap:IPOMember 2021-02-28 2021-03-02 0001164888 KBPH:SeriesBOnePreferredStockMember 2021-04-01 2021-12-31 0001164888 KBPH:SeriesBTwoPreferredStockMember 2021-04-01 2021-12-31 0001164888 KBPH:SeriesBOnePreferredStockMember 2021-10-01 2021-12-31 0001164888 KBPH:SeriesBThreePreferredStockMember 2021-04-01 2021-12-31 0001164888 us-gaap:CommonStockMember KBPH:AmendmentofPreferredStockMember 2021-10-01 2021-12-31 0001164888 us-gaap:CommonStockMember KBPH:AmendmentofPreferredStockMember 2021-04-01 2021-12-31 0001164888 us-gaap:CommonStockMember KBPH:AmendmentofPreferredStockMember 2021-03-31 0001164888 KBPH:TwoThousandAndEighteenStockOptionAndIncentivePlanMember 2018-04-01 2018-04-30 0001164888 KBPH:TwoThousandNineteenStockOptionAndIncentivePlanMember 2019-07-31 0001164888 KBPH:TwoThousandAndTwentyStockOptionAndIncentivePlanMember 2020-12-31 0001164888 KBPH:TwoThousandAndTwentyOneStockOptionAndIncentivePlanMember 2021-12-20 0001164888 KBPH:NonQualifiedStockOptionsMember 2021-10-01 2021-12-31 0001164888 KBPH:NonQualifiedStockOptionsMember 2020-10-01 2020-12-31 0001164888 KBPH:NonQualifiedStockOptionsMember 2021-04-01 2021-12-31 0001164888 KBPH:NonQualifiedStockOptionsMember 2020-04-01 2020-12-31 0001164888 us-gaap:WarrantMember 2021-04-01 2021-12-31 0001164888 srt:MinimumMember 2021-03-31 0001164888 srt:MaximumMember 2021-03-31 0001164888 srt:MinimumMember 2021-04-01 2021-12-31 0001164888 srt:MaximumMember 2021-04-01 2021-12-31 0001164888 srt:MinimumMember 2020-04-01 2021-03-31 0001164888 srt:MaximumMember 2020-04-01 2021-03-31 0001164888 2020-04-01 2021-03-31 0001164888 us-gaap:WarrantMember 2021-12-31 0001164888 us-gaap:WarrantMember 2020-03-31 0001164888 us-gaap:WarrantMember 2020-04-01 2020-12-31 0001164888 us-gaap:WarrantMember 2020-12-31 0001164888 us-gaap:WarrantMember 2019-04-01 2020-03-31 0001164888 us-gaap:WarrantMember 2021-03-31 0001164888 us-gaap:WarrantMember 2020-04-01 2021-03-31 0001164888 us-gaap:SubsequentEventMember 2022-01-01 2022-02-22 0001164888 us-gaap:SubsequentEventMember 2022-02-22 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure KBPH:Integer

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES

EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2021

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES

EXCHANGE ACT OF 1934

For the transition period from: _____________ to _____________

KYTO TECHNOLOGY AND LIFE SCIENCE, INC.

(Exact name of registrant as specified in its charter)

delaware	000-50390	65-1086538
(State or Other Jurisdiction	(Commission	(I.R.S. Employer
of Incorporation)	File Number)	Identification No.)

13050 Paloma Road, Los Altos Hills, CA 94022

(Address of Principal Executive Office) (Zip Code)

(650) 204 7896

(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

Title of each class		Trading Symbol		Exchange
Common stock		KBPH		OTC QB

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (ss. 232.405 of this chapter) during the preceding 12 (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☒
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Yes ☒ No

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). ☐ Yes ☒ No

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

13,287,621 Common Shares - $0.01 Par Value - as of February 18, 2022

Kyto Technology and Life Science, Inc.

For the quarterly period ended December 31, 2021

INDEX

	PART I. FINANCIAL INFORMATION

Item 1.	Financial Statements	3

	Condensed Statements of Assets and Liabilities as of December 31, 2021 (Unaudited) and March 31, 2021	3

	Unaudited Condensed Statements of Operations for the Three Months and Nine Months Ended December 31, 2021 and 2020	4

	Unaudited Condensed Statements of Changes in Net Assets for the Three Months and Nine Months Ended December 31, 2021 and 2020	5

	Unaudited Condensed Statements of Cash Flows for the Nine Months Ended December 31, 2021 and 2020	7

	Condensed Schedule of Investments as of December 31, 2021 (Unaudited) and March 31, 2021	8

	Notes to Unaudited Interim Condensed Financial Statements	13

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	29

Item 3.	Quantitative and Qualitative Disclosures About Market Risk.	33

Item 4.	Controls and Procedures.	33

	PART II. OTHER INFORMATION

Item 1.	Legal Proceedings.	35

Item 1A.	Risk Factors.	35

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.	35

Item 3.	Defaults Upon Senior Securities.	35

Item 4.	Mine Safety Disclosures	35

Item 5.	Other Information	35

Item 6.	Exhibits	35

	Signatures	37

PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

Kyto Technology and Life Science, Inc.

Condensed Statement of Assets and Liabilities

	December 31,			March 31,
	2021			2021
	(Unaudited)
ASSETS
Investments at fair value (cost of $8,926,469 and $5,686,545, respectively)	$	12,156,511		$	6,821,407
Cash		608,223			1,437,868
Other assets		293,564			169,891
Total Assets	$	13,058,298		$	8,429,166

LIABILITIES

Liabilities
Accounts payable and accrued liabilities	$	63,675		$	193,141
Accrued liabilities - related parties		83,000			51,420
Common stock subscription liability		-			1,191,442
Total Liabilities		146,675			1,436,003

Commitments and Contingencies (Note 3)		-			-

Net Assets
Preferred stock authorized but not designated, $0.01 par value 16,800,000 shares, none issued or outstanding as of December 31, 2021 and March 31, 2021, respectively		-			-
Class A (including Class A-1 and A-2) preferred convertible stock, $0.01 par value, 4,200,000 shares designated, 4,200,000 issued and outstanding as of December 31, 2021 and March 31, 2021, respectively; aggregate liquidation preference of $6,720,000 at December 31, 2021 and March 31, 2021, respectively		42,001			42,001
Class B (including Class B-1, B-2 and B-3) preferred convertible stock, $0.01 par value, 9,000,000 shares designated, 8,087,656 and 3,628,906 issued and outstanding as of December 31, 2021 and March 31, 2021, respectively, aggregate liquidation preference of $6,951,945 at December 31, 2021 and $2,903,125 at March 31, 2021, respectively		80,877			36,289
Preferred stock, value
Common stock, $0.01 par value, 40,000,000 shares authorized, 13,287,621 and 9,983,082 issued and outstanding as of December 31, 2021 and March 31 2021, respectively		132,876			99,831
Additional paid-in capital		44,630,564			39,772,228
Accumulated deficit		(31,974,695	)		(32,957,186	)

Total Net Assets		12,911,623			6,993,163

Total Liabilities and Net Assets	$	13,058,298		$	8,429,166

The accompanying notes are an integral part of these condensed interim financial statements.

Kyto Technology and Life Science, Inc.

Condensed Statement of Operations

(Unaudited)

	2021			2020			2021			2020
	For the Three months ended December 31,						For the Nine months ended December 31,
	2021			2020			2021			2020

INVESTMENT INCOME

Interest and other income	$	-		$	5		$	-		$	505

Total investment income		-			5			-			505

EXPENSES
Professional fees		98,241			91,669			371,600			168,212
Other operating expenses		273,473			241,047			741,089			363,983
Total expenses		371,714			332,716			1,112,689			532,195

Net investment loss		(371,714	)		(332,711	)		(1,112,689	)		(531,690	)

Net change in unrealized gain on investments		691,864			328,694			2,095,180			806,942

Net increase (decrease) in net assets resulting from operations		320,150			(4,017	)		982,491			275,252

Less: dividends attributable to Class B-1, B-2 and B-3		(131,999 )			-			(482,693)			-
Less: dividends attributable to Class B-1, B-2 and B-3 Preferred Stock (see Note 2 (I))		(131,999	)		-			(482,693	)		-

Net increase (decrease) in net assets resulting from operations attributable to Common Shareholders	$	188,151		$	(4,017	)	$	499,798		$	275,252

Basic earnings per Common Share,
Net increase in net assets resulting from operations per common share	$	0.01		$	-		$	0.04		$	0.04

Weighted average common shares outstanding		13,287,621			8,528,007			13,273,038			6,737,152

Fully-diluted earnings per Common Share,
Net increase in net assets resulting from operations per common share	$	0.01		$	-		$	0.02		$	0.02

Weighted average common shares outstanding		23,516,038			19,272,128			22,400,260			17,142,683

The accompanying notes are an integral part of these condensed interim financial statements.

Kyto Technology and Life Science, Inc.

Condensed Statement of Changes in Net Assets for the Three and Nine months ended December 31, 2021

(Unaudited)

	Preferred A (Including Class A-1, A-2)		Preferred A Stock (Including Class A-1, A-2)		Preferred B (Including Class B-1, B-2, B-3)		Preferred B Stock (Including Class B-1, B-2, B-3)		Common		Common Stock		Additional Paid-in		Accumulated
	Shares		Amount		Shares		Amount		Shares		Amount		Capital		Deficit			Total
Three months ended December 31, 2021
Balance, September 30, 2021		4,200,000	$	42,001		5,911,406	$	59,114		13,287,621	$	132,876	$	42,878,748	$	(32,294,845	)	$	10,817,894
Net increase in net assets resulting from operations		-		-		-		-		-		-		-		320,150			320,150
Sale of Class B-3 Preferred stock at $0.80 per share		-		-		2,176,250		21,763		-		-		1,719,237		-			1,741,000
Sale of Common stock
Sale of common stock $0.40 per share, shares
Exercise of stock options
Exercise of stock options, shares
Common stock issued for warrants and options exercise
Common stock issued for warrants and options exercise, shares
Compensation expense from stock options		-		-		-		-		-		-		32,579		-			32,579

Balance, December 31, 2021		4,200,000	$	42,001		8,087,656	$	80,877		13,287,621	$	132,876	$	44,630,564	$	(31,974,695	)	$	12,911,623

Nine months ended December 31, 2021
Balance, March 31, 2021		4,200,000	$	42,001		3,628,906	$	36,289		9,983,082	$	99,831	$	39,772,228	$	(32,957,186	)	$	6,993,163
Net increase in net assets resulting from operations		-		-		-		-		-		-		-		982,491			982,491
Sale of Class B-1 and B-3 Preferred stock at $0.80 per share		-		-		4,458,750		44,588		-		-		3,522,413		-			3,567,001
Sale of Common stock at $0.40 per share		-		-		-		-		3,285,789		32,858		1,281,459		-			1,314,317
Exercise of stock options		-		-		-		-		18,750		187		431		-			618
Compensation expense from stock options		-		-		-		-		-		-		54,033		-			54,033

Balance, December 31, 2021		4,200,000	$	42,001		8,087,656	$	80,877		13,287,621	$	132,876	$	44,630,564	$	(31,974,695	)	$	12,911,623

The accompanying notes are an integral part of these condensed interim financial statements.

Kyto Technology and Life Science, Inc.

Condensed Statement of Changes in Net Assets for the Three and Nine months ended December 31, 2020

(Unaudited)

	Preferred A		Preferred A Shares		Preferred B		Preferred B Shares		Common		Common Stock		Additional Paid-in		Accumulated
	Shares		Amount		Shares		Amount		Shares		Amount		Capital		Deficit			Total

Three months ended December 31, 2020
Balance, September 30, 2020		4,200,000	$	42,001		2,337,500	$	23,375		5,836,832	$	58,368	$	37,211,970	$	(33,104,983	)	$	4,230,731
Net decrease in net assets resulting from operations		-		-		-		-		-		-		-		(4,017	)		(4,017	)
Sale of Class B Preferred stock at $0.80 per share		-		-		753,906		7,539		-		-		595,586		-			603,125
Common stock issued for warrants and options exercise		-		-		-		-		3,965,000		39,650		1,526,580		-			1,566,230
Compensation expense from stock options		-		-		-		-		-		-		3,474		-			3,474

Balance, December 31, 2020		4,200,000	$	42,001		3,091,406	$	30,914		9,801,832	$	98,018	$	39,337,610	$	(33,109,000	)	$	6,399,543

Nine months ended December 31, 2020
Balance, March 31, 2020		4,200,000	$	42,001		812,500	$	8,125		5,836,832	$	58,368	$	35,943,369	$	(33,384,252	)	$	2,667,611
Net increase in net assets resulting from operations		-		-		-		-		-		-		-		275,252			275,252
Net increase (decrease) in net assets resulting from operations		-		-		-		-		-		-		-		275,252			275,252
Sale of Class B Preferred stock at $0.80 per share		-		-		2,278,906		22,789		-		-		1,850,336		-			1,873,125
Sale of Class B, B-1 and B-3 Preferred stock		-		-		2,278,906		22,789		-		-		1,850,336		-			1,873,125
Common stock issued for warrants and options exercise		-		-		-		-		3,965,000		39,650		1,526,579		-			1,566,229
Compensation expense from stock options		-		-		-		-		-		-		17,326		-			17,326

Balance, December 31, 2020		4,200,000	$	42,001		3,091,406	$	30,914		9,801,832	$	98,018	$	39,337,610	$	(33,109,000	)	$	6,399,543

The accompanying notes are an integral part of these condensed interim financial statements.

Kyto Technology and Life Science, Inc.

Condensed Statement of Cash Flows

(Unaudited)

	2021			2020
	Nine months months ended
	December 31,
	2021			2020

Operating activities:
Net increase in net assets resulting from operations	$	982,491		$	275,252
Adjustments to reconcile net increase in net assets resulting from operations to net cash used in operating activities
Net change in unrealized gain on investments		(2,095,180	)		(806,942	)
Stock option compensation expense		54,033			17,326
Change in operating assets and liabilities
Other assets		(123,673	)		500
Accounts payable and accrued liabilities		(129,466	)		47,708
Accrued liabilities to related parties		31,580			-
Purchases of investments		(3,328,478	)		(2,410,000	)
Proceeds from sale of investments		88,554			-
Net cash used in operating activities		(4,520,139	)		(2,876,156	)

Cash flows from financing activities:
Sale of Common stock in connection with preference rights (see Note 6)		122,875			-
Sale of Common stock from exercise of warrants and stock options		618			1,566,229
Sale of Class B-1 Preferred stock		1,626,000			1,873,125
Sale of Class B-3 Preferred stock		1,941,001			-
Deferred fundraising expenses		-			(36,409	)
Receipt of SBA loan		-			1,000
Advances from related party		-			2,250
Net cash provided by financing activities		3,690,494			3,406,195

Net increase/(decrease) in cash		(829,645	)		530,039

Cash, beginning of period		1,437,868			33,756
Cash, end of period	$	608,223		$	563,795

Supplemental cash flow information
Taxes paid	$	800		$	800
Supplemental schedule of noncash financing activities:
Conversion of common stock subscription liability to common stock	$	1,191,442		$	-

The accompanying notes are an integral part of these condensed interim financial statements.

Kyto Technology and Life Science, Inc.

Schedule of Investments as of December 31, 2021

(Unaudited)

	Portfolio Company		Industry	Investment	Cost		Fair value		% of net assets (a)
Convertible loan investments
	Abfero Pharmaceuticals Inc		Life science	Convertible Note, 6% due, December 2022	$	11,447	$	15,589		0.1	%
( i )	Achelios Therapeutics Inc.		Life science	Convertible Note, 8% due, December 2021		100,000		127,200		1.0	%
( i )	Achelios Therapeutics Inc.		Life science	Convertible Note, 8% due December 2021		25,000		30,540		0.2	%
( i )	Achelios Therapeutics Inc.		Life science	Convertible Note, 8% due December 2021		50,000		57,595		0.4	%
( i )	Achelios Therapeutics Inc.		Life science	Convertible Note Sidecar, 25% discount. No interest		50,000		50,000		0.4	%
	AOA DX Inc		Life science	Convertible Note, 4%, due May 2024		100,000		102,575		0.8	%
	Avisi Technologies Inc		Life science	Convertible Note, 8% due July 2022		50,000		55,688		0.4	%
	Basepaws Inc		Life science	Convertible Note, 1% due April 2020		50,000		244,980		1.9	%
	Basepaws Inc		Life science	Convertible Note, 6% due October 2023		150,000		150,000		1.2	%
( i )	Beam Semiconductor Inc	*	Technology	Convertible Note, 8% due April 2022		150,000		180,082		1.4	%
( i )	Beam Semiconductor Inc	*	Technology	Convertible Note, 8% due March 2021		50,000		57,299		0.4	%
( i )	Beam Semiconductor Inc	*	Technology	Convertible Note, 8% due March 2022		100,000		105,721		0.8	%
	CoLabs Inc		Life science	Convertible Note, 6% due February 2023		50,000		51,060		0.4	%
	Corinnova Inc		Life science	Convertible Note, 6% due December 2024		100,000		106,723		0.8	%
	Corinnova Inc		Life science	Convertible Note, 6% due December 2024		50,000		50,921		0.4	%
*	Cyberdontics Inc	*	Life science	Convertible Note, 8% due September 2022		30,000		71,733		0.6	%
*	Cyberdontics Inc	*	Life science	Convertible Note, 8% due February 2023		35,000		83,689		0.6	%
*	Cyberdontics Inc	*	Life science	Convertible Note, 0% no due date		35,000		35,000		0.3	%
	Deep Blue Medical Advances Inc		Life science	Convertible Note, 6% due June 2022		50,000		53,107		0.4	%
	Deep Blue Medical Advances Inc		Life science	Convertible Note, 6% due June 2022		50,000		50,181		0.4	%
	Every Key Inc		Technology	Convertible Note, 5% due December 2023		100,000		110,288		0.9	%
	Femto DX Inc.		Life science	Convertible Note, 12% due December 2022		100,000		100,526		0.8	%
	Identical Inc		Life science	Convertible Note, 2% due May 2022		100,000		102,279		0.8	%
( i )*	INBay Technology Inc	*	Technology	Convertible Note, 12% due October 2020		50,000		69,101		0.5	%
( i )*	INBay Technology Inc	*	Technology	Convertible Note, 12% due July 2021		30,000		38,936		0.3	%
( i )*	INBay Technology Inc	*	Technology	Convertible Note, 12% due February 2022		50,000		61,162		0.5	%
( i )*	INBay Technology Inc	*	Technology	Convertible Note, 12% due December 2022		40,000		45,168		0.3	%
( i )*	INBay Technology Inc	*	Technology	Convertible Note, 12% due December 2023		50,000		54,437		0.4	%
( i )*	INBay Technology Inc	*	Technology	Convertible Note, 12% due December 2023		25,000		25,001		0.2	%
*	Iris R&D Group Inc	*	Technology	Convertible Note, 8% May 2023		50,000		52,455		0.4	%
	Kiana Analytics Inc		Technology	Convertible Note, 3% December 2022		100,000		103,082		0.8	%
	Kitotech Medical Inc		Life science	Convertible Note, 6% due December 2020		100,000		247,654		1.9	%
	Kitotech Medical Inc		Life science	Convertible Note, 6% due November 2022		75,000		87,030		0.7	%
	Lifewave Biomedical Inc		Life science	Convertible Note, 6% due December 2020		30,000		34,187		0.3	%
	Lifewave Biomedical Inc		Life science	Convertible Note, 6% due December 2020		70,000		77,974		0.6	%
	Lifewave Biomedical Inc		Life science	Convertible Note, 6% due December 2021		50,000		51,915		0.4	%
	Lowell Therapeutics Inc		Life science	Convertible Note, 8% no due date		27,491		28,509		0.2	%
	mmTron Inc		Technology	Convertible Note, 4% due April 2023		100,000		102,038		0.8	%
	Navaux Inc		Life science	Convertible Note, 6% due December 2023		60,000		63,748		0.5	%
	Neuro42 Inc.		Life science	Convertible Note, 8% due December 2023		50,000		53,573		0.4	%
	Neuro42 Inc.		Life science	Convertible Note, 5% due November 2023		150,000		150,801		1.2	%
	Octagon Therapeutics Inc		Life science	Convertible Note, 5% due June 2021		50,000		52,979		0.4	%
	Octagon Therapeutics Inc		Life science	Convertible Note, 5% due June 2021		50,000		52,849		0.4	%
	Perikinetics Inc		Life science	Convertible Note, 6% due May 2022		100,000		106,838		0.8	%
	Preview Medical Inc		Life science	Convertible Note, 7% due May 2022		50,000		50,278		0.4	%
	Preview Medical Inc		Life science	Convertible Note, 7% due January 2023		100,000		106,712		0.8	%
	Promaxo Inc		Life science	Convertible note, 5% due July 2022		100,000		185,136		1.4	%
	Rheos Inc		Life science	Convertible note, 8% due August 2026		100,000		103,090		0.8	%
	Saccharo Inc		Life science	Convertible note, 7% due September 2022		50,000		51,697		0.4	%
	SageMedic Corp		Life science	Convertible Note, 8% April 2021 plus warrants		50,000		60,893		0.5	%
	SageMedic Corp		Life science	Convertible Note, 8% December 2022 plus warrants		75,000		81,460		0.6	%
	Seal Rock Therapeutics Inc		Life science	Convertible Note , 6% due June 2023		100,000		100,000		0.8	%
	Sensing Electromagnetic Plus Corp		Technology	Convertible Note, Fully reserved		50,000		1		0.0	%
	Sensing Electromagnetic Plus Corp		Technology	Convertible Note, Fully reserved		11,048		1		0.0	%
	Shyft (FKA Crater Group Inc)		Technology	Convertible Note, 6% due April 2023		100,000		100,000		0.8	%
	Single Pass Inc		Life science	Convertible Note, 6% April 2024		50,000		51,726		0.4	%
*	Valfix Medical Inc	*	Life science	Convertible Note, 8% December 2021		50,000		123,160		1.0	%
*	Xpan Inc	*	Life science	Convertible Note, 8% due March 2022		50,000		57,310		0.4	%
*	Xpan Inc	*	Life science	Convertible Note, 8% due June 2022		25,000		28,052		0.2	%
*	Xpan Inc	*	Life science	Convertible Note, 8% due June 2022		25,000		28,047		0.2	%
Total Convertible loan investments					$	3,879,986	$	4,679,776		36.2	%
	United States				$	3,034,986	$	3,563,423		27.6	%
	Canada					495,000		650,091		5.0	%
	Rest of World					350,000		466,262		3.6	%
Total Convertible loan investments					$	3,879,986	$	4,679,776		36.2	%

Continued to next page

The accompanying notes are an integral part of these condensed interim financial statements.

Kyto Technology and Life Science, Inc.

Schedule of Investments as of December 31, 2021

(Unaudited)

	Portfolio Company		Industry	Investment	Cost		Fair value		% of net assets (a)
Preferred stock investments
	Altis Biosystems		Life science	22,028 shares of Series Seed Preferred	$	50,000	$	50,000	0.4	%
	Astrocyte Pharmaceuticals Inc		Life science	260,756 shares of Series A Preferred		100,000		100,000	0.8	%
	Cnote Group, Inc		Fintech	84,655 shares of series Seed-2 Preferred (converted SAFE)		51,500		59,783	0.5	%
	Cnote Group, Inc		Fintech	93,807 shares of Series Seed-3 Preferred (converted note)		50,000		66,247	0.5	%
	Colabs Inc		Life science	147,058 shares of Series A-1 Preferred		50,000		50,000	0.4	%
*	Connectus Services Ltd	*	Technology	31,348 shares of Series Seed Preferred		100,000		100,000	0.8	%
	Deep Blue Medical Advances Inc		Life science	10,474 shares of Series A Preferred		49,996		49,997	0.4	%
	Distasense Inc (FKA Life Detection Technologies Inc		Life science	117,813 shares of Series C Preferred		50,000		50,000	0.4	%
	Eumentis Thereapeutics Inc		Life science	85,009 shares of Series A Preferred		100,000		100,000	0.8	%
	FemtoDX Inc		Life science	42,436 shares of Series A Preferred		100,000		290,046	2.2	%
	Healionics Corporation		Life science	35,075 of Series A-1 Preferred		100,000		100,000	0.8	%
	i-Lumen Scientific Inc.		Life science	50,000 shares of Series A Preferred plus warrants		50,000		50,000	0.4	%
	i-Lumen Scientific Inc.		Life science	50,000 shares of Series A Preferred plus warrants		50,000		50,000	0.4	%
	Inhalon Biopharma Inc		Life science	18,843 shares of Series Seed Preferred		99,997		256,198	2.0	%
	Kitotech Medical Inc		Life science	49,027shares of Series B Preferred		74,998		74,998	0.6	%
	Light Line Medical Inc		Life science	62,849 shares of Series Seed Preferred (converted note)		30,000		38,031	0.3	%
	Light Line Medical Inc		Life science	141,871 shares of Series Seed Preferred (converted note)		70,000		106,049	0.8	%
	Light Line Medical Inc		Life science	40,323 shares of Series Seed preferred		25,000		25,000	0.2	%
	Light Line Medical Inc		Life science	72,464 shares of Series A Preferred plus warrants		50,000		50,000	0.4	%
	Lowell Therapeutics Inc		Life science	20,000 shares of Series A Preferred		50,000		50,000	0.4	%
	Lowell Therapeutics Inc		Life science	20,000 shares of Series A Preferred		50,000		50,000	0.4	%
	Lowell Therapeutics Inc		Life science	25,000 shares of Series B Preferred		100,000		100,001	0.8	%
	Makani Science Inc		Life science	172,413 shares of Series Seed Preferred		50,000		50,000	0.4	%
	Micronic Technologies Inc		Technology	51,929 shares of Series Seed-1 Preferred plus warrants		100,000		100,000	0.8	%
	Nanochon Inc		Life science	200,401 shares of Series Seed Preferred		50,000		50,000	0.4	%
	Neuroflow Inc		Life science	98,684 shares of Series Seed -2 Preferred		150,000		540,053	4.2	%
	Neuroflow Inc		Life science	20,429 shares of Series B Preferred		100,000		136,829	1.1	%
	New View Surgical, Inc.		Life science	53,825 shares of Series A-1 Preferred		75,000		75,000	0.6	%
	New View Surgical, Inc.		Life science	58,220 shares of Series A-1 Preferred		100,000		100,000	0.8	%
*	Orion Biotechnology Inc	*	Life science	5,824 shares of Series A Preferred		100,000		100,000	0.8	%
	Otomagnetics Inc		Life science	16,538 shares of Series A-1 Preferred		100,000		100,000	0.8	%
	Partheous Inc		Life science	50,000 shares of Series A Preferred		50,000		50,000	0.4	%
	Promaxo		Life science	104,248 shares of Series B-1 Preferred, (converted note)		250,000		1,034,684	8.0	%
	SageMedic Corp		Life science	12,717 shares of Series A Preferred		10,389		10,389	0.1	%
	Seal Rock Therapeutics, Inc.		Life science	68,075 shares of Series Seed Preferred, (converted note)		78,000		199,375	1.5	%
	Shyft (FKA Crater Group Inc)		Technology	42,657 shares of Series A-1 Preferred (converted note)		51,500		107,059	0.8	%
	Shyft (FKA Crater Group Inc)		Technology	28,147 shares of Series A Preferred (converted note)		50,000		91,771	0.7	%
	Shyft (FKA Crater Group Inc)		Technology	21,774 shares of Series A-1 Preferred plus warrants		50,000		70,990	0.5	%
( i )	Trellis Bioscience LLC		Life science	50,000 shares of Series B Preferred plus warrants		50,000		50,000	0.4	%
( i )	Trellis Bioscience LLC		Life science	50,000 shares of Series B Preferred plus warrants		50,000		50,000	0.4	%
( i )	Trellis Bioscience LLC		Life science	100,000 shares of Series B Preferred plus warrants		100,000		100,000	0.8	%
	Trio Labs Inc		Life science	29,809 shares of Series Seed Preferred		50,000		50,000	0.4	%
*	Valfix Medical Inc	*	Life science	27,217 shares of Series Seed Preferred		50,000		105,607	0.8	%
	Vesteck Inc		Life science	34,783 shares of Series A preferred		100,000		100,000	0.8	%
	Visgenx Inc		Life science	7,833 shares of Series Seed-1 Preferred (converted note)		30,000		46,352	0.4	%
	Visgenx Inc		Life science	4,132 shares of Series Seed Preferred (converted note)		25,000		25,648	0.2	%
	Visgenx Inc		Life science	2,480 shares of Series Seed Preferred (converted note)		15,003		15,391	0.1	%
Total Preferred stock investments					$	3,286,383	$	5,225,498	40.5	%
	United States				$	3,036,383	$	4,919,891	38.2	%
	Canada					200,000		200,000	1.5	%
	Rest of World					50,000		105,607	0.8	%
Total Preferred stock investments					$	3,286,383	$	5,225,498	40.5	%

Common stock investments
*	BendaRX Corp	*	Life science	12,500 Common shares	$	100,000	$	150,000	1.2	%
*	BendaRX Corp	*	Life science	12,500 Common shares		100,000		150,000	1.2	%
	Kuantsol Inc		Technology	133.333 Common shares		25,000		25,000	0.2	%
Total Common stock investments					$	225,000	$	325,000	2.5	%
	United States				$	25,000	$	25,000	0.2	%
	Canada					200,000		300,000	2.3	%
	Rest of World					-		-	0.0	%
Total Common stock investments					$	225,000	$	325,000	2.5	%

Continued to next page

The accompanying notes are an integral part of these condensed interim financial statements.

Kyto Technology and Life Science, Inc.

Schedule of Investments as of December 31, 2021

(Unaudited)

	Portfolio Company		Industry	Investment	Cost		Fair value		% of net assets (a)
Public common stock investments
	Boardwalk Tech		Technology	75,000 Common shares	$	65,600	$	70,000	0.5	%
	Boardwalk Tech		Technology	150,000 Common shares		73,500		86,505	0.7	%
	Sanaby Health Acquisition Corp 1		Life science	50,000 Common shares		100,000		473,732	3.7	%
Total Public common stock investments					$	239,100	$	630,237	4.9	%
	United States				$	239,100	$	630,237	4.9	%
	Canada					-		-	0.0	%
	Rest of World					-		-	0.0	%
Total Public common stock investments					$	239,100	$	630,237	4.9	%

SAFE investments
	AOA DX inc		Life science	SAFE	$	50,000	$	50,000	0.4	%
*	Infinidome Ltd	*	Technology	SAFE		50,000		50,000	0.4	%
*	Infinidome Ltd	*	Technology	SAFE		50,000		50,000	0.4	%
*	Infinidome Ltd	*	Technology	SAFE		100,000		100,000	0.8	%
*	Madorra Inc	*	Life science	SAFE		100,000		100,000	0.8	%
	Mitre Medical Corp		Life science	SAFE		75,000		75,000	0.6	%
	Mitre Medical Corp		Life science	SAFE		50,000		50,000	0.4	%
*	Orion Biotechnology Inc.	*	Life science	SAFE		100,000		100,000	0.8	%
*	Polymertal Ltd	*	Technology	SAFE		150,000		150,000	1.2	%
Total SAFE investments					$	725,000	$	725,000	5.6	%
	United States					175,000		175,000	1.3	%
	Canada					100,000		100,000	0.8	%
	Rest of World					450,000		450,000	3.5	%
Total SAFE investments					$	725,000	$	725,000	5.6	%

Other investments
	Enduralock LLC		Technology	34.1 Series A-1 Ownership Units	$	30,000	$	30,000	0.2	%
	Enduralock LLC		Technology	39.7 Series A-1 Ownership Units		35,000		35,000	0.3	%
	Exodos Life Sciences LP		Life science	Class A-1 Preferred Ownership Units		206,000		206,000	1.6	%
	Green Sun Medical LLC		Life science	2,193 Class A-1 Ownership units		50,000		50,000	0.4	%
	Green Sun Medical LLC		Life science	1,096 Class A-1 Ownership units		25,000		25,000	0.2	%
	Green Sun Medical LLC		Life science	1,096 Class A-1 Ownership units		25,000		25,000	0.2	%
	Green Sun Medical LLC		Life science	4,386 Class A-1 Ownership units		100,000		100,000	0.8	%
	Riso Capital Fund I, LP		Technology	Ownership units		50,000		50,000	0.4	%
	Riso Capital Fund I, LP		Technology	Ownership units		50,000		50,000	0.4	%
Total Other investments					$	571,000	$	571,000	4.4	%
	United States				$	521,000	$	571,000	4.4	%
	Canada					-		-	0.0	%
	Rest of World					50,000		-	0.0	%
Total Other investments					$	571,000	$	571,000	4.4	%

Total investments					$	8,926,469	$	12,156,511	94.2	%
	United States				$	7,031,469	$	9,884,551	76.6	%
	Canada					995,000		1,250,091	9.7	%
	Rest of World					900,000		1,021,869	7.9	%
Total investments					$	8,926,469	$	12,156,511	94.2	%
	(a) based on total net assets of $ 12,911,623
( i )	Kyto management sit on the Board of these companies.
*	These companies are headquartered outside of the US.

The accompanying notes are an integral part of these condensed interim financial statements.

Kyto Technology and Life Science, Inc.

Schedule of Investments as of March 31, 2021

(Unaudited)

	Portfolio Company		Industry	Investment	Cost		Fair value		% of net assets (a)
Convertible loan investments
( i )	Achelios Therapeutics Inc.		Life science	Convertible Note, 8% due, December 2021	$	100,000	$	121,173		1.7	%
( i )	Achelios Therapeutics Inc.		Life science	Convertible Note, 8% due December 2021		25,000		29,033		0.4	%
( i )	Achelios Therapeutics Inc.		Life science	Convertible Note, 8% due December 2021		50,000		54,581		0.8	%
	Avisi Technologies Inc		Life science	Convertible Note, 8% due July 2022		50,000		52,674		0.8	%
	Basepaws Inc		Life science	Convertible Note, 1% due April 2020		50,000		162,319		2.3	%
( i )	Beam Semiconductor Inc	*	Technology	Convertible Note, 8% due April 2022		150,000		171,041		2.4	%
( i )	Beam Semiconductor Inc	*	Technology	Convertible Note, 8% due March 2021		50,000		54,285		0.8	%
	Corinnova Inc		Life science	Convertible Note, 6% due December 2024		100,000		102,318		1.5	%
	Cyberdontics Inc	*	Life science	Convertible Note, 8% due September 2022		30,000		33,768		0.5	%
	Cyberdontics Inc	*	Life science	Convertible Note, 8% due February 2023		35,000		38,053		0.5	%
	Cyberdontics Inc	*	Life science	Convertible Note, 0% no due date		35,000		36,296		0.5	%
	Deep Blue Medical Advances Inc		Life science	Convertible Note, 6% due June 2022		50,000		50,863		0.7	%
	Every Key Inc		Technology	Convertible Note, 5% due December 2023		100,000		106,521		1.5	%
	Identical Inc		Life science	Convertible Note, 2% due May 2022		100,000		100,844		1.4	%
	INBay Technology Inc	*	Technology	Convertible Note, 12% due October 2020		50,000		59,721		0.9	%
	INBay Technology Inc	*	Technology	Convertible Note, 12% due July 2021		30,000		34,149		0.5	%
	INBay Technology Inc	*	Technology	Convertible Note, 12% due February 2022		50,000		56,640		0.8	%
	INBay Technology Inc	*	Technology	Convertible Note, 12% due December 2022		40,000		41,552		0.6	%
	Kiana Analytics Inc		Technology	Convertible Note, 3% December 2022		100,000		100,847		1.4	%
	Kitotech Medical Inc		Life science	Convertible Note, 6% due December 2020		100,000		243,133		3.5	%
	Kitotech Medical Inc		Life science	Convertible Note, 6% due November 2022		75,000		83,738		1.2	%
	Lifewave Biomedical Inc		Life science	Convertible Note, 6% due December 2020		30,000		32,830		0.5	%
	Lifewave Biomedical Inc		Life science	Convertible Note, 6% due December 2020		70,000		74,810		1.1	%
	Navaux Inc		Life science	Convertible Note, 6% due December 2023		60,000		61,036		0.9	%
	Neuro42 Inc.		Life science	Convertible Note, 8% due December 2023		50,000		50,559		0.7	%
	Octagon Therapeutics Inc		Life science	Convertible Note, 5% due June 2021		50,000		51,110		0.7	%
	Octagon Therapeutics Inc		Life science	Convertible Note, 5% due June 2021		50,000		50,966		0.7	%
	Perikinetics Inc		Life science	Convertible Note, 6% due May 2022		100,000		102,318		1.5	%
	Preview Medical Inc		Life science	Convertible Note, 7% due January 2023		100,000		101,918		1.5	%
	SageMedic Corp		Life science	Convertible Note, 8% April 2021 plus warrants		50,000		57,879		0.8	%
	SageMedic Corp		Life science	Convertible Note, 8% December 2022 plus warrants		75,000		77,086		1.1	%
	Sensing Electromagnetic Plus Corp		Technology	Convertible Note, Fully reserved		50,000		1		0.0	%
	Sensing Electromagnetic Plus Corp		Technology	Convertible Note, Fully reserved		11,048		1		0.0	%
	Valfix Medical Inc	*	Life science	Convertible Note, 8% December 2021		50,000		52,510		0.8	%
	Xpan Inc	*	Life science	Convertible Note, 8% due March 2022		50,000		54,296		0.8	%
	Xpan Inc	*	Life science	Convertible Note, 8% due June 2022		25,000		26,545		0.4	%
	Xpan Inc	*	Life science	Convertible Note, 8% due June 2022		25,000		26,540		0.4	%
Total Convertible loan investments					$	2,216,048	$	2,553,954		36.5	%
	United States				$	1,596,048	$	1,868,557		26.7	%
	Canada					370,000		407,561		5.8	%
	Rest of World					250,000		277,836		4.0	%
Total Convertible loan investments					$	2,216,048	$	2,553,954		36.5	%

Preferred stock investments
	Altis Biosystems		Life science	22,028 shares of Series Seed Preferred	$	50,000	$	50,000		0.7	%
	Astrocyte Pharmaceuticals Inc		Life science	260,756 shares of Series A Preferred		100,000		100,000		1.4	%
	Cnote Group, Inc		Fintech	84,655 shares of series Seed-2 Preferred (converted SAFE)		51,500		59,783		0.9	%
	Cnote Group, Inc		Fintech	93,807 shares of Series Seed-3 Preferred (converted note)		50,000		66,247		0.9	%
	Colabs Inc		Life science	147,058 shares of Series A-1 Preferred		50,000		50,000		0.7	%
	Connectus Services Ltd	*	Technology	31,348 shares of Series Seed Preferred		100,000		100,000		1.4	%
	Deep Blue Medical Advances Inc		Life science	10,474 shares of Series A Preferred		49,997		49,997		0.7	%
	Eumentis Thereapeutics Inc		Life science	85,009 shares of Series A Preferred		100,000		100,000		1.4	%
	FemtoDX Inc		Life science	42,436 shares of Series A Preferred		100,000		159,835		2.3	%
	i-Lumen Scientific Inc.		Life science	50,000 shares of Series A Preferred plus warrants		50,000		50,000		0.7	%
	i-Lumen Scientific Inc.		Life science	50,000 shares of Series A Preferred plus warrants		50,000		50,000		0.7	%
	Inhalon Biopharma Inc		Life science	18,843 shares of Series Seed Preferred		99,997		99,997		1.4	%
	Light Line Medical Inc		Life science	62,849 shares of Series Seed Preferred (converted note)		30,000		38,031		0.5	%
	Light Line Medical Inc		Life science	141,871 shares of Series Seed Preferred (converted note)		70,000		106,049		1.5	%
	Light Line Medical Inc		Life science	40,323 shares of Series Seed preferred		25,000		25,000		0.4	%
	Light Line Medical Inc		Life science	72,464 shares of Series A Preferred plus warrants		50,000		50,000		0.7	%
	Lowell Therapeutics Inc		Life science	20,000 shares of Series A Preferred		50,000		50,000		0.7	%
	Lowell Therapeutics Inc		Life science	20,000 shares of Series A Preferred		50,000		50,000		0.7	%
	Micronic Technologies Inc		Technology	51,929 shares of Series Seed-1 Preferred plus warrants		100,000		100,000		1.4	%
	Neuroflow Inc		Life science	98,684 shares of Series Seed -2 Preferred		150,000		224,998		3.2	%
	Neuroflow Inc		Life science	20,429 shares of Series B Preferred		100,000		212,497		3.0	%
	New View Surgical, Inc.		Life science	53,825 shares of Series A-1 Preferred		75,000		75,000		1.1	%

Continued to next page

The accompanying notes are an integral part of these condensed interim financial statements.

Kyto Technology and Life Science, Inc.

Schedule of Investments as of March 31, 2021

(Unaudited)

	Portfolio Company		Industry	Investment	Cost		Fair value		% of net assets (a)
Preferred stock investments (continued)
	Otomagnetics Inc		Life science	16,538 shares of Series A-1 Preferred plus warrants	$	100,000	$	100,000	1.4	%
	Promaxo		Life science	104,248 shares of Series B-1 Preferred, (converted note)		250,000		531,738	7.6	%
	Seal Rock Therapeutics, Inc.		Life science	68,075 shares of Series Seed Preferred, (converted note)		78,000		80,329	1.1	%
	Shyft (FKA Crater Group Inc)		Technology	42,657 shares of Series A-1 Preferred		51,500		97,940	1.4	%
	Shyft (FKA Crater Group Inc)		Technology	28,147 shares of Series A Preferred (converted note)		50,000		64,626	0.9	%
	Shyft (FKA Crater Group Inc)		Technology	21,774 shares of Series A-1 Preferred (converted note)		50,000		50,000	0.7	%
( i )	Trellis Bioscience LLC		Life science	50,000 shares of Series B Preferred plus warrants		50,000		50,000	0.7	%
( i )	Trellis Bioscience LLC		Life science	50,000 shares of Series B Preferred plus warrants		50,000		50,000	0.7	%
( i )	Trellis Bioscience LLC		Life science	100,000 shares of Series B Preferred plus warrants		100,000		100,000	1.4	%
	Valfix Medical Inc	*	Life science	27,217 shares of Series Seed Preferred		50,000		50,000	0.7	%
	Visgenx Inc		Life science	7,833 shares of Series Seed-1 Preferred (converted note)		30,000		46,352	0.7	%
	Visgenx Inc		Life science	4,132 shares of Series Seed Preferred (converted note)		25,000		25,648	0.4	%
	Visgenx Inc		Life science	2,480 shares of Series Seed Preferred (converted note)		15,003		15,391	0.2	%
Total Preferred stock investments					$	2,450,997	$	3,129,458	44.8	%
	United States				$	2,300,997	$	2,979,458	42.6	%
	Canada					100,000		100,000	1.4	%
	Rest of World					50,000		50,000	0.7	%
Total Preferred stock investments					$	2,450,997	$	3,129,458	44.8	%

Common stock investments
	BendaRX Corp	*	Life science	12,500 Common shares	$	100,000	$	150,000	2.1	%
	BendaRX Corp	*	Life science	12,500 Common shares		100,000		150,000	2.1	%
	Boardwalk Tech		Technology	150,000 Common shares		73,500		91,995	1.3	%
Total Common stock investments					$	273,500	$	391,995	5.6	%
	United States				$	73,500	$	91,995	1.3	%
	Canada					200,000		300,000	4.3	%
	Rest of World					-		-	0.0	%
Total Common stock investments					$	273,500	$	391,995	5.6	%

SAFE investments
	Infinidome Ltd	*	Technology	SAFE	$	50,000	$	50,000	0.7	%
	Infinidome Ltd	*	Technology	SAFE

Kyto Technology & Life Science, Inc. 10-Q